Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 724 articles:
HTML format
Text format



Single Articles


    September 2018
  1. ARRIGO M, Ishihara S, Feliot E, Rudiger A, et al
    New-onset atrial fibrillation in critically ill patients and its association with mortality: A report from the FROG-ICU study.
    Int J Cardiol. 2018;266:95-99.
    PubMed     Text format     Abstract available


  2. CASTELLETTI S, Dagradi F, Goulene K, Danza AI, et al
    A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
    Int J Cardiol. 2018;266:89-94.
    PubMed     Text format     Abstract available


  3. AESCHBACHER S, O'Neal WT, Krisai P, Loehr L, et al
    Relationship between QRS duration and incident atrial fibrillation.
    Int J Cardiol. 2018;266:84-88.
    PubMed     Text format     Abstract available


  4. NAKAMURA K, Funabashi N, Naito S, Uehara M, et al
    Reply to letter "anatomical relationship of coronary sinus/great cardiac vein and LCx artery along mitral annulus in atrial-fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;266:160.
    PubMed     Text format    


  5. RIENSTRA M, van Veldhuisen DJ
    Atrial fibrillation is more troublesome in heart failure patients with preserved compared to those with reduced ejection fraction.
    Int J Cardiol. 2018;266:155-156.
    PubMed     Text format    


  6. KADHIM K, Lau DH, Linz D, Sanders P, et al
    Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
    Int J Cardiol. 2018;266:153-154.
    PubMed     Text format    


  7. STROKER E, de Asmundis C, Chierchia GB
    Cryoballoon ablation for the treatment of atrial fibrillation: Does it stand the test of time?
    Int J Cardiol. 2018;266:151-152.
    PubMed     Text format    


  8. BALIK M
    New-onset atrial fibrillation in critically ill patients - Implications for rhythm rather than rate control therapy?
    Int J Cardiol. 2018;266:147-148.
    PubMed     Text format    


  9. VERRIER RL
    The power of the patch: A smart way to track risk for Torsades de pointes in congenital and drug-induced long QT syndromes?
    Int J Cardiol. 2018;266:145-146.
    PubMed     Text format    


  10. HEIJMAN J, Dobrev D, Crijns HJGM
    Electrocardiographic characteristics associated with atrial fibrillation - What do they tell us?
    Int J Cardiol. 2018;266:143-144.
    PubMed     Text format    


  11. BARRA S, Baran J, Narayanan K, Boveda S, et al
    Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2018;266:136-142.
    PubMed     Text format     Abstract available


  12. RIVASI G, Solari D, Rafanelli M, Ceccofiglio A, et al
    Incidence and predictors of syncope recurrence after cardiac pacing in patients with carotid sinus syndrome.
    Int J Cardiol. 2018;266:119-123.
    PubMed     Text format     Abstract available


  13. GOYAL P, Almarzooq ZI, Cheung J, Kamel H, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Int J Cardiol. 2018;266:112-118.
    PubMed     Text format     Abstract available


  14. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation.
    Int J Cardiol. 2018;266:106-111.
    PubMed     Text format     Abstract available


  15. GRIMALDI-BENSOUDA L, Wedemeyer H, Wiegand J, Lohse AW, et al
    Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study.
    Int J Cardiol. 2018;266:100-105.
    PubMed     Text format     Abstract available


  16. JONES DA, Rathod KS, Williamson A, Harrington D, et al
    The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.
    Int J Cardiol. 2018;266:1-6.
    PubMed     Text format     Abstract available


    August 2018
  17. PARK JW, Sievert H, Kleinecke C, Vaskelyte L, et al
    Left atrial appendage occlusion with lambre in atrial fibrillation: Initial European experience.
    Int J Cardiol. 2018;265:97-102.
    PubMed     Text format     Abstract available


  18. CHAN YH, Yeh YH, Hsieh MY, Chang CY, et al
    The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan.
    Int J Cardiol. 2018;265:83-89.
    PubMed     Text format     Abstract available


  19. JIANG P, Yang FO, Wu J, He Y, et al
    Left atrial low-voltage areas: A powerful predictor in paroxysmal atrial fibrillation recurrence after catheter ablation?
    Int J Cardiol. 2018;265:238.
    PubMed     Text format    


  20. MASUDA M
    Reply to the letter to the editor: "Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation".
    Int J Cardiol. 2018;265:134.
    PubMed     Text format    


  21. PATTI G, Cavallari I, Hanon O, De Caterina R, et al
    The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.
    Int J Cardiol. 2018;265:118-124.
    PubMed     Text format     Abstract available


  22. RUBBOLI A
    Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
    Int J Cardiol. 2018;264:95-96.
    PubMed     Text format    


  23. FRIBERG L
    Safety of apixaban in combination with dronedarone in patients with atrial fibrillation.
    Int J Cardiol. 2018;264:85-90.
    PubMed     Text format     Abstract available


  24. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
    Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
    Int J Cardiol. 2018;264:64-69.
    PubMed     Text format     Abstract available


  25. PASTORI D, Lip GYH, Farcomeni A, Del Sole F, et al
    Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Int J Cardiol. 2018;264:58-63.
    PubMed     Text format     Abstract available


  26. EL-BATTRAWY I, Borggrefe M, Akin I
    Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:103.
    PubMed     Text format    


  27. POPPE KK, Doughty RN
    Response to letter from El-Battrawy et al.: Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:102.
    PubMed     Text format    


    July 2018
  28. SAEED S, Gerdts E
    Incremental prognostic value of left atrial function indices in the prediction of incident atrial fibrillation in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2018;263:7-8.
    PubMed     Text format    


  29. ODENING KE
    Another step towards a mechanism-based, subtype-specific therapy in long QT syndrome.
    Int J Cardiol. 2018;263:67-68.
    PubMed     Text format    


  30. MELE D, Luisi GA, Ferrari R
    Evaluation of left ventricular systolic function during atrial fibrillation: Is it reliable?
    Int J Cardiol. 2018;263:63-64.
    PubMed     Text format    


  31. DONS M, Jensen JS, Olsen FJ, de Knegt MC, et al
    Global longitudinal strain corrected by RR-interval is a superior echocardiographic predictor of outcome in patients with atrial fibrillation.
    Int J Cardiol. 2018;263:42-47.
    PubMed     Text format     Abstract available


  32. MODIN D, Olsen FJ, Pedersen S, Jensen JS, et al
    Measures of left atrial function predict incident atrial fibrillation in STEMI patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2018;263:1-6.
    PubMed     Text format     Abstract available


  33. BURLACU A, Covic A
    'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
    Int J Cardiol. 2018;262:43-44.
    PubMed     Text format    


    June 2018
  34. SPOSATO LA, Lopes RD
    Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
    Int J Cardiol. 2018;261:99-100.
    PubMed     Text format    


  35. LI Y, Pastori D, Guo Y, Wang Y, et al
    Risk factors for new-onset atrial fibrillation: A focus on Asian populations.
    Int J Cardiol. 2018;261:92-98.
    PubMed     Text format     Abstract available


  36. HSIEH CY, Lee CH, Wu DP, Sung SF, et al
    Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.
    Int J Cardiol. 2018;261:68-72.
    PubMed     Text format     Abstract available


  37. CHAO TF, Chen SA
    What to do when patients having a high risk of new-onset atrial fibrillation are identified?
    Int J Cardiol. 2018;261:101-102.
    PubMed     Text format    


  38. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available


  39. KOHNO T, Kimura T, Fukunaga K, Yamasawa W, et al
    Prevalence and clinical characteristics of obstructive- and central-dominant sleep apnea in candidates of catheter ablation for atrial fibrillation in Japan.
    Int J Cardiol. 2018;260:99-102.
    PubMed     Text format     Abstract available


  40. TSE G, Liu T, Baranchuk A
    Authors' reply: Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:112.
    PubMed     Text format    


  41. SUN GZ, Wang HY, Zhou Y, Sun YX, et al
    Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:111.
    PubMed     Text format    


  42. SHIZUTA S, Kawaji T, Kimura T
    Reply to "Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmtonary vein isolation?"
    Int J Cardiol. 2018;260:110.
    PubMed     Text format    


  43. ORCZYKOWSKI M, Szumowski L
    Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmonary vein isolation?
    Int J Cardiol. 2018;260:109.
    PubMed     Text format    


  44. LINZ D, Nalliah C, Kalman J, Sanders P, et al
    Routine screening for sleep apnea in patients with atrial fibrillation: Ready for primetime?
    Int J Cardiol. 2018;260:103-104.
    PubMed     Text format    


    May 2018
  45. MARTINS D, Ovaert C, Khraiche D, Boddaert N, et al
    Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy: A paediatric case series.
    Int J Cardiol. 2018 May 31. pii: S0167-5273(18)31054.
    PubMed     Text format     Abstract available


  46. CHELU MG, Li N
    Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet?
    Int J Cardiol. 2018 May 30. pii: S0167-5273(18)32813.
    PubMed     Text format    


  47. CARMO AAL, de Sousa MR, Agudelo JF, Boersma E, et al
    Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.
    Int J Cardiol. 2018 May 29. pii: S0167-5273(18)30210.
    PubMed     Text format     Abstract available


  48. BEN-DOV N, Newman D, Crystal E
    Robotic magnetic catheter navigation as a first step in the automation of the ablation procedures for ventricular arrhythmia.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)33283.
    PubMed     Text format    


  49. MUTHALALY RG, Koplan BA, Albano A, North C, et al
    Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study.
    Int J Cardiol. 2018 May 24. pii: S0167-5273(18)31107.
    PubMed     Text format     Abstract available


  50. SHULMAN E, Shah T, Mazori AY, Chudow JJ, et al
    Heart failure and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 May 22. pii: S0167-5273(17)37213.
    PubMed     Text format    


  51. FENDER AC, Dobrev D
    The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes.
    Int J Cardiol. 2018 May 19. pii: S0167-5273(18)33126.
    PubMed     Text format    


  52. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
    Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
    PubMed     Text format     Abstract available


  53. MESQUITA J, Ferreira AM, Cavaco D, Carmo P, et al
    Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure.
    Int J Cardiol. 2018;259:82-87.
    PubMed     Text format     Abstract available


  54. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: Two-year outcome and predictors of recurrence after a single procedure.
    Int J Cardiol. 2018;259:76-81.
    PubMed     Text format     Abstract available


  55. ROMERO J, Di Biase L
    Empirical cavotricuspid isthmus line for atrial fibrillation ablation is futile "Repetita Iuvant".
    Int J Cardiol. 2018;259:107-108.
    PubMed     Text format    


  56. KOSIUK J, de Potter T, Linz D
    The role of electroanatomical mapping in individualized treatment of paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;259:105-106.
    PubMed     Text format    


  57. YASUDA S, Kaikita K, Ogawa H, Akao M, et al
    Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study.
    Int J Cardiol. 2018 May 2. pii: S0167-5273(17)36755.
    PubMed     Text format     Abstract available


  58. TSATSOPOULOU A
    Arrhythmogenic right ventricular cardiomyopathy and pregnancy.
    Int J Cardiol. 2018;258:199-200.
    PubMed     Text format    


  59. GANDJBAKHCH E, Varlet E, Duthoit G, Fressart V, et al
    Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Int J Cardiol. 2018;258:172-178.
    PubMed     Text format     Abstract available


  60. ABUBAKAR H, Osman M, Akintoye E, Subahi A, et al
    Intra-thoracic Impedance and the Onset of Atrial and Ventricular Tachyarrhythmias: A Meta-analysis.
    Int J Cardiol. 2018;258:144-150.
    PubMed     Text format     Abstract available


  61. WANG L, Bi Y, Yu M, Li T, et al
    Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.
    Int J Cardiol. 2018;258:138-143.
    PubMed     Text format     Abstract available


  62. BOVEDA S, Chalbia TE, Jacob S, Combes S, et al
    Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators.
    Int J Cardiol. 2018;258:133-137.
    PubMed     Text format     Abstract available


    April 2018
  63. AMIN AS, Reckman YJ, Arbelo E, Spanjaart AM, et al
    SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Int J Cardiol. 2018 Apr 27. pii: S0167-5273(17)32831.
    PubMed     Text format     Abstract available


  64. ZOPPELLARO G, Zanella L, Denas G, Gennaro N, et al
    Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(18)30527.
    PubMed     Text format    


  65. LUO J, Li H, Qin X, Liu B, et al
    Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Apr 23. pii: S0167-5273(17)37900.
    PubMed     Text format     Abstract available


  66. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
    Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
    PubMed     Text format     Abstract available


  67. MASUDA M, Fujita M, Iida O, Okamoto S, et al
    Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;257:97-101.
    PubMed     Text format     Abstract available


  68. DE POOTER J, Kamoen V, El Haddad M, Stroobandt R, et al
    Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy.
    Int J Cardiol. 2018;257:84-91.
    PubMed     Text format     Abstract available


  69. BARNETT AS, Cyr DD, Goodman SG, Levitan BS, et al
    Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.
    Int J Cardiol. 2018;257:78-83.
    PubMed     Text format     Abstract available


  70. TSATSOPOULOU A, Bossone E
    Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics.
    Int J Cardiol. 2018;257:371-377.
    PubMed     Text format     Abstract available


  71. MANSORI K, Ayubi E
    Comments on association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2018;257:32.
    PubMed     Text format    


  72. GOUDIS CA, Vasileiadis IE, Liu T
    CHA2DS2-VASc: An eligible score for atrial fibrillation prediction in chronic obstructive pulmonary disease?
    Int J Cardiol. 2018;257:299.
    PubMed     Text format    


  73. KHAZAEI S, Karami M, Veisani Y
    Comment on "Alcohol and incident atrial fibrillation-A systematic review and meta-analysis".
    Int J Cardiol. 2018;257:117.
    PubMed     Text format    


  74. AYUBI E, Safiri S
    Comments on clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2018;257:116.
    PubMed     Text format    


  75. AZADANI PN, Marrouche NF, Wilson BD
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:113-114.
    PubMed     Text format    


  76. DENG Y, Qin F, Liu Q, Wu Z, et al
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:110.
    PubMed     Text format    


  77. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    


  78. SUN C, Wang W, Leng T, Shi Y, et al
    Letter regarding Nakamura et al. "Anatomical relationship of coronary sinus/great cardiac vein and left circumflex coronary artery along mitral annulus in atrial fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;256:26.
    PubMed     Text format    


  79. SANCHIS-GOMAR F, Lippi G, Cervellin G, Perez-Quilis C, et al
    PAFIYAMA syndrome evidence in highly trained population.
    Int J Cardiol. 2018;256:10.
    PubMed     Text format    


  80. BRUNETTI ND, Tarantino N, Santoro F, Correale M, et al
    "PAFIYAMA" syndrome; further evidence on a novel clinical entity.
    Int J Cardiol. 2018;256:9.
    PubMed     Text format    


  81. BANDYOPADHYAY D, Ashish K, Hajra A, Ghosh RK, et al
    An interesting insight into breakfast and cardiovascular disease.
    Int J Cardiol. 2018;256:7.
    PubMed     Text format    


    March 2018
  82. HAHAD O, Beutel M, Gori T, Schulz A, et al
    Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study.
    Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37174.
    PubMed     Text format     Abstract available


  83. HA FJ, Barra S, Brown AJ, Begley DB, et al
    Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
    Int J Cardiol. 2018 Mar 21. pii: S0167-5273(18)31037.
    PubMed     Text format     Abstract available


  84. YU L, Meng G, Huang B, Zhou X, et al
    A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
    Int J Cardiol. 2018;255:92-98.
    PubMed     Text format     Abstract available


  85. MISHIMA RS, Elliott AD, Sanders P, Linz D, et al
    Microbiome and atrial fibrillation.
    Int J Cardiol. 2018;255:103-104.
    PubMed     Text format    


  86. TSUJI Y, Dobrev D
    Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death.
    Int J Cardiol. 2018;255:101-102.
    PubMed     Text format    


  87. EICKHOLT C
    Finding the right timing in cryoballoon ablation for pulmonary vein isolation.
    Int J Cardiol. 2018;255:99-100.
    PubMed     Text format    


  88. LEE HF, Chan YH, Tu HT, Kuo CT, et al
    The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)37808.
    PubMed     Text format     Abstract available


  89. DIEMBERGER I, Fantecchi E, Reggiani MLB, Martignani C, et al
    Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)38078.
    PubMed     Text format     Abstract available


  90. PROIETTI M, Romiti GF, Romanazzi I, Farcomeni A, et al
    Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(18)31060.
    PubMed     Text format     Abstract available


  91. BISSON A, Bodin A, Clementy N, Bernard A, et al
    Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
    Int J Cardiol. 2018 Mar 7. pii: S0167-5273(18)30084.
    PubMed     Text format     Abstract available


  92. KAWADA T
    Periodic limb movements of sleep and atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2018;254:345.
    PubMed     Text format    


  93. YALTA K, Taylan G, Gurlertop Y
    Atrial fibrillation in the setting of takotsubo cardiomyopathy: Just the tip of the iceberg?
    Int J Cardiol. 2018;254:174.
    PubMed     Text format    


  94. PROIETTI M
    The dangerous combination of atrial fibrillation and hypertension: An urgent need to handle complexity.
    Int J Cardiol. 2018;254:167-169.
    PubMed     Text format    


  95. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    


  96. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.
    Int J Cardiol. 2018;254:157-161.
    PubMed     Text format     Abstract available


  97. DAN GA, Badila E, Weiss E, Laroche C, et al
    Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
    Int J Cardiol. 2018;254:136-141.
    PubMed     Text format     Abstract available


  98. POPPE KK, Doughty RN, Harwood M, Barber PA, et al
    Identification, risk assessment, and management of patients with atrial fibrillation in a large primary care cohort.
    Int J Cardiol. 2018;254:119-124.
    PubMed     Text format     Abstract available


  99. SANTORO F, Di Biase M, Brunetti ND
    Effect of sex hormones in Takotsubo cardiomyopathy: Just matter of arrhythmias or also outcomes?
    Int J Cardiol. 2018;254:246-247.
    PubMed     Text format    


  100. GIUSTETTO C, Cerrato N, Gaita F
    Drug-induced type 1 Brugada ECG: Lights and shadows.
    Int J Cardiol. 2018;254:170-171.
    PubMed     Text format    


  101. DE LAZZARI M, Perazzolo Marra M
    The myocardial bright signal: The arrhythmogenic link between function and myocardial fibrosis.
    Int J Cardiol. 2018;254:258-259.
    PubMed     Text format    


    February 2018
  102. TENMA T, Yokoshiki H, Mitsuyama H, Watanabe M, et al
    Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator.
    Int J Cardiol. 2018 Feb 20. pii: S0167-5273(17)37446.
    PubMed     Text format     Abstract available


  103. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    


  104. BEYER-WESTENDORF J, Kreutz R, Posch F, Ay C, et al
    The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.
    Int J Cardiol. 2018;253:71-77.
    PubMed     Text format     Abstract available


  105. CONTE G, Caputo ML, Volders PGA, Luca A, et al
    Concealed abnormal atrial phenotype in patients with Brugada syndrome and no history of atrial fibrillation.
    Int J Cardiol. 2018;253:66-70.
    PubMed     Text format     Abstract available


  106. NAMMAS W, Kiviniemi T, Schlitt A, Rubboli A, et al
    Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.
    Int J Cardiol. 2018;253:35-39.
    PubMed     Text format     Abstract available


  107. FENDER AC
    PS. It was me all along! Emergence of phosphatidylserine in the procoagulant state in atrial fibrillation.
    Int J Cardiol. 2018 Feb 12. pii: S0167-5273(18)30663.
    PubMed     Text format    


  108. SHIMOKAWA H, Yamashita T, Uchiyama S, Kitazono T, et al
    The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Feb 3. pii: S0167-5273(18)30592.
    PubMed     Text format     Abstract available


  109. BARI V, Ranucci M, De Maria B, Cairo B, et al
    Model-based directional analysis of cardiovascular variability identifies patients developing atrial fibrillation after coronary artery bypass grafting.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37276.
    PubMed     Text format     Abstract available


  110. LIU FZ, Liao HT, Lin WD, Xue YM, et al
    Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37479.
    PubMed     Text format     Abstract available


  111. PROIETTI M, Lip GYH
    Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials.
    Int J Cardiol. 2018;252:96-100.
    PubMed     Text format     Abstract available


  112. CHUGH SS
    Heart failure and atrial fibrillation: Can we break this nexus?
    Int J Cardiol. 2018;252:142-143.
    PubMed     Text format    


  113. ZIFF OJ, Carter PR, McGowan J, Uppal H, et al
    The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry.
    Int J Cardiol. 2018;252:117-121.
    PubMed     Text format     Abstract available


  114. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    


  115. DRAGO F
    Postoperative arrhythmias after AVSD repair: The lack of regular periodic rhythm surveillance allows you to see only the tip of the iceberg.
    Int J Cardiol. 2018;252:94-95.
    PubMed     Text format    


    January 2018
  116. KAPA S, Vaidya V, Hodge DO, McLeod CJ, et al
    Right ventricular dysfunction in congenitally corrected transposition of the great arteries and risk of ventricular tachyarrhythmia and sudden death.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36055.
    PubMed     Text format     Abstract available


  117. TE ALD, Lo LW, Lin YJ, Chang SL, et al
    Vasovagal responses during cryoballoon pulmonary vein isolation in paroxysmal atrial fibrillation predict favorable mid-term outcomes.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36027.
    PubMed     Text format     Abstract available


  118. CAVALLARI I, Ruff CT, Nordio F, Deenadayalu N, et al
    Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2018 Jan 26. pii: S0167-5273(17)35262.
    PubMed     Text format     Abstract available


  119. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    


  120. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation impacts the outcome in Takotsubo syndrome.
    Int J Cardiol. 2018;251:57.
    PubMed     Text format    


  121. GALLAGHER C, Hendriks JML, Lau DH, Sanders P, et al
    Alcohol and atrial fibrillation.
    Int J Cardiol. 2018;251:56.
    PubMed     Text format    


  122. YANG Y, Hu D, Peng D
    Should small-to-moderate alcohol consumption be recommended for healthy middle-aged women?
    Int J Cardiol. 2018;251:55.
    PubMed     Text format    


  123. PARREIRA L, Marinheiro R
    "Excessive" atrial ectopy is worse than "frequent" atrial ectopy.
    Int J Cardiol. 2018;251:54.
    PubMed     Text format    


  124. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    


  125. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    


  126. KISS A, Podesser BK
    Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling.
    Int J Cardiol. 2018;250:60-61.
    PubMed     Text format    


    December 2017
  127. PASTORI D, Pignatelli P, Sciacqua A, Perticone M, et al
    Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Int J Cardiol. 2017 Dec 24. pii: S0167-5273(17)36573.
    PubMed     Text format     Abstract available


  128. HEIJMAN J, Kirchner D, Kunze F, Chretien EM, et al
    Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.
    Int J Cardiol. 2017 Dec 22. pii: S0167-5273(17)37262.
    PubMed     Text format     Abstract available


  129. ANTZELEVITCH C, Di Diego JM, Argenziano M
    Tpeak-Tend as a predictor of ventricular arrhythmogenesis.
    Int J Cardiol. 2017;249:75-76.
    PubMed     Text format    


  130. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    


  131. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    


  132. SPARTALIS M, Tzatzaki E, Dimitroulis D, Spartalis E, et al
    The emerging role of hybrid ablation for atrial fibrillation.
    Int J Cardiol. 2017;249:257.
    PubMed     Text format    


  133. BERTAGLIA E, Anselmino M, Zorzi A, Russo V, et al
    NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Int J Cardiol. 2017;249:179-183.
    PubMed     Text format     Abstract available


  134. DING M, Fratiglioni L, Johnell K, Fastbom J, et al
    Atrial fibrillation and use of antithrombotic medications in older people: A population-based study.
    Int J Cardiol. 2017;249:173-178.
    PubMed     Text format     Abstract available


  135. CHIU SN, Huang SC, Wang JK, Lu CW, et al
    Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: Implications for the mechanism of ventricular arrhythmia.
    Int J Cardiol. 2017;249:156-160.
    PubMed     Text format     Abstract available


  136. TSATSOPOULOU A
    Desmoplakin: Highlights on a left ventricular arrhythmogenic disorder.
    Int J Cardiol. 2017;249:324-325.
    PubMed     Text format    


  137. WAKILI R, Dobrev D
    Response to: "The emerging role of hybrid ablation for ablation" by Spartialis M. et al.
    Int J Cardiol. 2017;249:258.
    PubMed     Text format    


  138. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    


  139. ESTEVE-PASTOR MA, Rivera-Caravaca JM, Roldan V, Vicente V, et al
    Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
    Int J Cardiol. 2017 Dec 14. pii: S0167-5273(17)34423.
    PubMed     Text format     Abstract available


  140. BUIATTI A, von Olshausen G, Martens E, Schinke K, et al
    Balloon angioplasty versus stenting for pulmonary vein stenosis after pulmonary vein isolation for atrial fibrillation: A meta-analysis.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)35398.
    PubMed     Text format     Abstract available


  141. LIEDER H, Breithardt G, Heusch G
    Fatal attraction - A brief pathophysiology of the interaction between atrial fibrillation and myocardial ischemia.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)36897.
    PubMed     Text format     Abstract available


  142. LINZ D, Elliott AD, Marwick TH, Sanders P, et al
    Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy.
    Int J Cardiol. 2017;248:208-210.
    PubMed     Text format    


  143. NORTAMO S, Ukkola O, Lepojarvi S, Kentta T, et al
    Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2017;248:173-178.
    PubMed     Text format     Abstract available


  144. LIMONGELLI G, Sarubbi B
    Atrial arrhythmias in adults with congenital heart disease. Listening to your heart sound can save your life.
    Int J Cardiol. 2017;248:159-160.
    PubMed     Text format    


    November 2017
  145. REUSSER A, Blum S, Aeschbacher S, Eggimann L, et al
    QTc interval, cardiovascular events and mortality in patients with atrial fibrillation.
    Int J Cardiol. 2017 Nov 24. pii: S0167-5273(17)35267.
    PubMed     Text format     Abstract available


  146. STROKER E, Kupics K, de Asmundis C, Mugnai G, et al
    Atrial fibrillation ablation with the second generation cryoballoon: Multicenter propensity score matched comparison between freezing strategies.
    Int J Cardiol. 2017 Nov 22. pii: S0167-5273(17)35978.
    PubMed     Text format     Abstract available


  147. PERTICONE M, Sciacqua A, Tripepi G, Miceli S, et al
    Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation.
    Int J Cardiol. 2017 Nov 20. pii: S0167-5273(17)34491.
    PubMed     Text format     Abstract available


  148. YUCEL O, Yucel H, Zorlu A
    D-dimer is a predictor of cardiovascular death, and new-onset atrial fibrillation in patients with systolic heart failure.
    Int J Cardiol. 2017;247:39.
    PubMed     Text format    


  149. FOSSATI C, Volterrani M, Punzo N, Campolongo G, et al
    Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation.
    Int J Cardiol. 2017;247:37.
    PubMed     Text format    


  150. BAI F, Qin F, Liu Q, Tu T, et al
    Is the increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias accurate?
    Int J Cardiol. 2017;247:23.
    PubMed     Text format    


  151. MERT KU, Dural M, Mert GO
    Is electrical cardioversion doable in atrial fibrillation without transesophageal echocardiography?
    Int J Cardiol. 2017;247:20.
    PubMed     Text format    


  152. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    


  153. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    


  154. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    


  155. LIU Q, Qin F, Liu N, Tu T, et al
    Is the new risk factor algorithm accurate to predict frequent premature ventricular contraction-induced cardiomyopathy?
    Int J Cardiol. 2017;247:27.
    PubMed     Text format    


  156. PHILLIPS KP
    Response by Phillips KP et al. to letter regarding article 'Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation'.
    Int J Cardiol. 2017;247:22.
    PubMed     Text format    


  157. MAURIZI N, Olivotto I, Cecchi F
    Reply to: Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:55.
    PubMed     Text format    


  158. QIN F, Liu Q, Liu Z
    Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:54.
    PubMed     Text format    


  159. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    


  160. GALLAGHER C, Hendriks JML, Elliott AD, Wong CX, et al
    Alcohol and incident atrial fibrillation - A systematic review and meta-analysis.
    Int J Cardiol. 2017;246:46-52.
    PubMed     Text format     Abstract available


    October 2017
  161. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available


  162. GILLJAM T, Haugaa KH, Jensen HK, Svensson A, et al
    Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
    Int J Cardiol. 2017 Oct 21. pii: S0167-5273(17)34381.
    PubMed     Text format     Abstract available


  163. POLIN B, Behar N, Galand V, Auffret V, et al
    Clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2017;245:168-173.
    PubMed     Text format     Abstract available


  164. LAHEWALA S, Arora S, Patel P, Kumar V, et al
    Atrial fibrillation: Utility of CHADS2 and CHA2DS2-VASc scores as predictors of readmission, mortality and resource utilization.
    Int J Cardiol. 2017;245:162-167.
    PubMed     Text format     Abstract available


  165. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    


  166. TADROS R, Wilde AAM
    Revisiting the sensitivity of sodium channel blocker testing in Brugada syndrome using obligate transmittance.
    Int J Cardiol. 2017;245:183-184.
    PubMed     Text format    


  167. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.
    Int J Cardiol. 2017 Oct 9. pii: S0167-5273(17)33443.
    PubMed     Text format     Abstract available


  168. LEINONEN JT, Crotti L, Djupsjobacka A, Castelletti S, et al
    The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34464.
    PubMed     Text format     Abstract available


  169. BANERAS J, Ferreira-Gonzalez I, Marsal JR, Barrabes JA, et al
    Short-term exposure to air pollutants increases the risk of ST elevation myocardial infarction and of infarct-related ventricular arrhythmias and mortality.
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34210.
    PubMed     Text format     Abstract available


  170. TSE G, Wong CW, Gong M, Wong WT, et al
    Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)35239.
    PubMed     Text format     Abstract available


  171. AGNIHOTRI K, Pothineni NV, Charilaou P, Vaidya VR, et al
    Impact of atrial fibrillation on outcomes with motor vehicle accidents.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)33412.
    PubMed     Text format     Abstract available


  172. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as new biomarkers in risk stratification in patient with atrial fibrillation.
    Int J Cardiol. 2017;244:297.
    PubMed     Text format    


  173. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    


  174. ZHAO Y, Qin F, He B, Liu X, et al
    Is atrial fibrillation itself the cause of increased platelet reactivity intrinsically?
    Int J Cardiol. 2017;244:205.
    PubMed     Text format    


  175. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Int J Cardiol. 2017;244:204.
    PubMed     Text format    


  176. HEIJMAN J, Dobrev D, Crijns HJGM
    Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation?
    Int J Cardiol. 2017;244:202-203.
    PubMed     Text format    


    September 2017
  177. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available


  178. POLOVINA M, Dikic D, Vlajkovic A, Vilotijevic M, et al
    Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)34881.
    PubMed     Text format     Abstract available


  179. YAMADA S, Lo LW, Chen SA
    Reply to letter to the editor: "A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation".
    Int J Cardiol. 2017;243:282.
    PubMed     Text format    


  180. YI X, Feng G, Jiang X
    A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation.
    Int J Cardiol. 2017;243:281.
    PubMed     Text format    


  181. WAKILI R, Dobrev D
    Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?
    Int J Cardiol. 2017;243:276-278.
    PubMed     Text format    


  182. HUIKURI HV
    Prediction of benefits from prophylactic implantable cardioverter-defibrillator therapy.
    Int J Cardiol. 2017;243:274-275.
    PubMed     Text format    


  183. FENDER AC, Dobrev D
    Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelled.
    Int J Cardiol. 2017;243:272-273.
    PubMed     Text format    


  184. DAN GA
    Atrial fibrillation: Applying evidence out of the box.
    Int J Cardiol. 2017;243:270-271.
    PubMed     Text format    


  185. SALIH M, Smer A, Charnigo R, Ayan M, et al
    Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2017;243:258-262.
    PubMed     Text format     Abstract available


  186. POURTAU L, Sellal JM, Lacroix R, Poncelet P, et al
    Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
    Int J Cardiol. 2017;243:216-222.
    PubMed     Text format     Abstract available


  187. RODRIGUEZ-MANERO M, Lopez-Pardo E, Cordero A, Kredieh O, et al
    Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area.
    Int J Cardiol. 2017;243:211-215.
    PubMed     Text format     Abstract available


  188. KAWAJI T, Shizuta S, Morimoto T, Aizawa T, et al
    Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience.
    Int J Cardiol. 2017 Sep 15. pii: S0167-5273(17)33302.
    PubMed     Text format     Abstract available


  189. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    


  190. YANG Y, Liu Q, Liu Z, Zhou S, et al
    Is flat QRS complex in lead aVL the characteristic of ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus?
    Int J Cardiol. 2017;242:47.
    PubMed     Text format    


  191. NEEFS J, van den Berg NWE, Limpens J, Berger WR, et al
    Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."
    Int J Cardiol. 2017;242:23.
    PubMed     Text format    


  192. ALEXANDRE J, Sezai A, Milliez P
    Comment on "Aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al.
    Int J Cardiol. 2017;242:22.
    PubMed     Text format    


  193. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    


  194. LENNERZ C, Barman M, Tantawy M, Sopher M, et al
    Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis.
    Int J Cardiol. 2017 Sep 1. pii: S0167-5273(17)32407.
    PubMed     Text format     Abstract available


  195. WEI X, An Q
    Prognostic value of left atrial size and function in adults with tetralogy of Fallot.
    Int J Cardiol. 2017;242:36.
    PubMed     Text format    


    August 2017
  196. PROIETTI M, Laroche C, Nyvad O, Haberka M, et al
    Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)32291.
    PubMed     Text format     Abstract available


  197. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available


  198. BELHASSEN B, Milman A
    Syncope in Brugada syndrome: A plea for thorough anamnesis and EPS. The lessons from our journey in the region of Piedmont, Italy.
    Int J Cardiol. 2017;241:241-242.
    PubMed     Text format    


  199. RHODES AC, Murray B, Tichnell C, James CA, et al
    Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
    Int J Cardiol. 2017 Aug 14. pii: S0167-5273(17)31856.
    PubMed     Text format     Abstract available


  200. WANG M, Li S, Zhou X, Huang B, et al
    Increased inflammation promotes ventricular arrhythmia through aggravating left stellate ganglion remodeling in a canine ischemia model.
    Int J Cardiol. 2017 Aug 12. pii: S0167-5273(17)31266.
    PubMed     Text format     Abstract available


  201. DE LUCA L, Casella G, Rubboli A, Gonzini L, et al
    Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation.
    Int J Cardiol. 2017 Aug 10. pii: S0167-5273(17)32498.
    PubMed     Text format     Abstract available


  202. MASUDA K, Ishizu T, Gosho M, Aonuma K, et al
    Reply to: Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017 Aug 8. pii: S0167-5273(17)33784.
    PubMed     Text format    


  203. DOMINGUEZ F, Climent V, Zorio E, Ripoll-Vera T, et al
    Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Int J Cardiol. 2017 Aug 7. pii: S0167-5273(17)33243.
    PubMed     Text format     Abstract available


  204. SABERIAN S, Badin A, Siebert V, Roy A, et al
    Prevalence and predictors of inappropriate anticoagulation in patients with a CHA2DS2-VASc score of 0 and atrial fibrillation.
    Int J Cardiol. 2017 Aug 2. pii: S0167-5273(17)31619.
    PubMed     Text format     Abstract available


  205. TINKER A
    The mechanisms of ventricular arrhythmia in Chagas disease.
    Int J Cardiol. 2017;240:372-373.
    PubMed     Text format    


  206. WALDO AL
    Atrial fibrillation and atrial flutter: Two sides of the same coin!
    Int J Cardiol. 2017;240:251-252.
    PubMed     Text format    


  207. ROMERO J, Estrada R, Holmes A, Goodman-Meza D, et al
    Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillation.
    Int J Cardiol. 2017;240:246-250.
    PubMed     Text format     Abstract available


    July 2017
  208. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Association between gamma-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2017 Jul 21. pii: S0167-5273(16)34879.
    PubMed     Text format     Abstract available


  209. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available


  210. STIERMAIER T, Santoro F, Eitel C, Graf T, et al
    Prevalence and prognostic relevance of atrial fibrillation in patients with Takotsubo syndrome.
    Int J Cardiol. 2017 Jul 18. pii: S0167-5273(17)33182.
    PubMed     Text format     Abstract available


  211. ZHANG N, Tse G, Liang X, Li G, et al
    Telomere length: A newly marker for predicting atrial fibrillation?
    Int J Cardiol. 2017;239:21.
    PubMed     Text format    


  212. AYUBI E, Safiri S, Mansournia MA
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017;239:20.
    PubMed     Text format    


  213. ZENG J, Wang X
    Metabolic disorder caused by antipsychotic treatment may facilitate the development of atrial fibrillation.
    Int J Cardiol. 2017;239:14.
    PubMed     Text format    


  214. ROSATO E, Tubani L, Gigante A
    QTc interval prolongation in systemic sclerosis.
    Int J Cardiol. 2017;239:34.
    PubMed     Text format    


  215. DE LUCA G, Bosello SL, Canestrari G, Cavalli G, et al
    QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.
    Int J Cardiol. 2017;239:33.
    PubMed     Text format    


  216. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    


  217. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available


  218. BAYKANER T, Zaman JAB, Rogers AJ, Navara R, et al
    Spatial relationship of sites for atrial fibrillation drivers and atrial tachycardia in patients with both arrhythmias.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)31816.
    PubMed     Text format     Abstract available


  219. SUN C, Qin F, Tu T, Liu Q, et al
    Is antiarrhythmic medication superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation?
    Int J Cardiol. 2017 Jul 6. pii: S0167-5273(17)33752.
    PubMed     Text format    


  220. AZADANI PN, King JB, Kheirkhahan M, Chang L, et al
    Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)32655.
    PubMed     Text format    


    June 2017
  221. CHOU RH, Lo LW, Leu HB
    Autonomic dysfunction plays a decisive role in the arrhythmia initiation, whereas metabolic disorders facilitate further atrial remodeling in antipsychotic-related atrial fibrillation.
    Int J Cardiol. 2017 Jun 30. pii: S0167-5273(17)30750.
    PubMed     Text format    


  222. OKAWA K, Miyoshi T, Tsukuda S, Hara S, et al
    Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.
    Int J Cardiol. 2017 Jun 19. pii: S0167-5273(17)32623.
    PubMed     Text format     Abstract available


  223. CROTTI L, Kotta MC
    The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
    Int J Cardiol. 2017;237:45-48.
    PubMed     Text format     Abstract available


  224. MIYAZAKI S, Ebana Y, Liu L, Nakamura H, et al
    Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)30813.
    PubMed     Text format     Abstract available


  225. STYLES K, Sapp J Jr, Gardner M, Gray C, et al
    The influence of sex and age on ventricular arrhythmia in a population-based registry.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32392.
    PubMed     Text format     Abstract available


  226. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available


  227. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available


  228. ELLERMANN C, Wolfes J, Kochhauser S, Dechering DG, et al
    Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)32130.
    PubMed     Text format     Abstract available


  229. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available


  230. CHANG KW, Arbit B, Hsu JC
    Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32256.
    PubMed     Text format     Abstract available


  231. STEFFEL J, Ruff CT, Hamershock RA, Murphy SA, et al
    First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32088.
    PubMed     Text format     Abstract available


  232. BELLMANN B, Fiebach JB, Guttmann S, Lin T, et al
    Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
    Int J Cardiol. 2017 Jun 1. pii: S0167-5273(17)32336.
    PubMed     Text format     Abstract available


  233. D'ANGELO RN, Pickett CC
    Diagnostic yield of device interrogation in the evaluation of syncope in an elderly population.
    Int J Cardiol. 2017;236:164-167.
    PubMed     Text format     Abstract available


  234. LUO B, Zhou G, Guo X, Liu X, et al
    Long-term outcome of catheter ablation for left posterior fascicular ventricular tachycardia with the development of left posterior fascicular block and characteristics of repeat procedures.
    Int J Cardiol. 2017;236:203-208.
    PubMed     Text format     Abstract available


  235. TURAGAM MK, Afzal MR, Reddy M, Pillarisetti J, et al
    Practice variation in the re-initiation of dofetilide: An observational study.
    Int J Cardiol. 2017;236:221-225.
    PubMed     Text format     Abstract available


  236. CHANG JH, Chang SL, Hong PD, Chen PN, et al
    Epigallocatechin-3-gallate modulates arrhythmogenic activity and calcium homeostasis of left atrium.
    Int J Cardiol. 2017;236:174-180.
    PubMed     Text format     Abstract available


  237. HAMMWOHNER M, Goette A
    Kidney diseases and NOAC therapy: Is there a light at the end of the tunnel?
    Int J Cardiol. 2017;236:162-163.
    PubMed     Text format    


    May 2017
  238. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available


  239. DA COSTA A, Guichard JB, Romeyer-Bouchard C
    Reply to the letter to Editor "Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?"
    Int J Cardiol. 2017;235:202.
    PubMed     Text format    


  240. LIANG J, Cha Y
    Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?
    Int J Cardiol. 2017;235:201.
    PubMed     Text format    


  241. MALLIKETHI-REDDY S, Akintoye E, Trehan N, Sharma S, et al
    Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations.
    Int J Cardiol. 2017;235:114-117.
    PubMed     Text format     Abstract available


  242. TAKAHASHI Y, Izumi C, Miyake M, Imanaka M, et al
    Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease.
    Int J Cardiol. 2017 May 11. pii: S0167-5273(16)32716.
    PubMed     Text format     Abstract available


  243. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)31514.
    PubMed     Text format     Abstract available


  244. CASTELLETTI S, Vischer AS, Syrris P, Crotti L, et al
    Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)30578.
    PubMed     Text format     Abstract available


  245. WONG CX, Gan SW, Lee SW, Gallagher C, et al
    Atrial fibrillation and risk of hip fracture: A population-based analysis of 113,600 individuals.
    Int J Cardiol. 2017 May 5. pii: S0167-5273(16)34388.
    PubMed     Text format     Abstract available


  246. CHEN S, Zhou G, Liu S
    Pulmonary vein isolation only may not enough for persistent atrial fibrillation.
    Int J Cardiol. 2017;234:123.
    PubMed     Text format    


  247. KOZA Y, Karakelleoglu S
    Are single nucleotide polymorphisms sufficient to explain recurrence of atrial fibrillation after catheter ablation?
    Int J Cardiol. 2017;234:122.
    PubMed     Text format    


    April 2017
  248. LIU J, Wang N, Qin L, Liu J, et al
    Integrating genotypes in the SAMe-TT2R2 score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin.
    Int J Cardiol. 2017 Apr 29. pii: S0167-5273(17)30949.
    PubMed     Text format     Abstract available


  249. SUNDBOLL J, Hovath-Puho E, Adelborg K, Ording A, et al
    Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
    Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30248.
    PubMed     Text format     Abstract available


  250. XIE J, Chahal CAA, Covassin N, Schulte PJ, et al
    Periodic limb movements of sleep are associated with an increased prevalence of atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2017 Apr 22. pii: S0167-5273(16)34493.
    PubMed     Text format     Abstract available


  251. KIMURA Y, Noda T, Matsuyama TA, Otsuka Y, et al
    Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30192.
    PubMed     Text format     Abstract available


  252. HUNG Y, Lo LW, Lin YJ, Chang SL, et al
    Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(16)33852.
    PubMed     Text format     Abstract available


  253. BARKAS F, Elisaf M, Korantzopoulos P, Tsiara S, et al
    The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)31069.
    PubMed     Text format     Abstract available


  254. HATEGAN L, Csanyi B, Ordog B, Kakonyi K, et al
    A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)30089.
    PubMed     Text format     Abstract available


  255. BAYKANER T, Zografos TA, Zaman JAB, Pantos I, et al
    Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi.
    Int J Cardiol. 2017 Apr 19. pii: S0167-5273(17)30158.
    PubMed     Text format     Abstract available


  256. QIU J, Tu T, Zhou S, Liu Q, et al
    Disordered myocardium energy metabolism in the progression of atrial fibrillation in highly trained endurance athletes.
    Int J Cardiol. 2017;233:95.
    PubMed     Text format    


  257. LU Z, He B, Jiang H
    Increasing interest in ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2017;233:104.
    PubMed     Text format    


  258. YANG Y, Liu Q, Liu Z, Zhou S, et al
    Insight of ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2017;233:103.
    PubMed     Text format    


  259. O'BRIEN B, Zafar H, De Freitas S, Sharif F, et al
    Transseptal puncture - Review of anatomy, techniques, complications and challenges.
    Int J Cardiol. 2017;233:12-22.
    PubMed     Text format     Abstract available


  260. PARK KM, Im SI, Park SJ, Kim JS, et al
    Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy.
    Int J Cardiol. 2017;233:37-42.
    PubMed     Text format     Abstract available


  261. SPITZER SG, Leitz P, Langbein A, Karolyi L, et al
    Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34442.
    PubMed     Text format     Abstract available


  262. YAMASAKI H, Lustgarten D, Cerkvenik J, Birnie D, et al
    Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)33104.
    PubMed     Text format     Abstract available


  263. MURA M, Mehta A, Ramachandra CJ, Zappatore R, et al
    The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(17)30298.
    PubMed     Text format     Abstract available


  264. ANSELMINO M, Garberoglio L, Gili S, Bertaglia E, et al
    Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
    Int J Cardiol. 2017 Apr 8. pii: S0167-5273(16)32868.
    PubMed     Text format     Abstract available


  265. ARENAS DE LARRIVA AP, Norby FL, Chen LY, Soliman EZ, et al
    Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Int J Cardiol. 2017 Apr 6. pii: S0167-5273(16)34419.
    PubMed     Text format     Abstract available


  266. MERY B, Guichard JB, Guy JB, Vallard A, et al
    Atrial fibrillation in cancer patients: Hindsight, insight and foresight.
    Int J Cardiol. 2017 Apr 5. pii: S0167-5273(17)30307.
    PubMed     Text format     Abstract available


  267. TANG LH, Kikkenborg Berg S, Christensen J, Lawaetz J, et al
    Patients' preference for exercise setting and its influence on the health benefits gained from exercise-based cardiac rehabilitation.
    Int J Cardiol. 2017;232:33-39.
    PubMed     Text format     Abstract available


  268. KOSTIC T, Momcilovic S, Perisic ZD, Apostolovic SR, et al
    Manifestations of Lyme carditis.
    Int J Cardiol. 2017;232:24-32.
    PubMed     Text format     Abstract available


  269. ABRICH VA, Ramakrishna H, Mehta A, Mookadam F, et al
    The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.
    Int J Cardiol. 2017;232:243-246.
    PubMed     Text format     Abstract available


    March 2017
  270. KIM IS, Sohn J, Lee SJ, Park JK, et al
    Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable cardioverter defibrillators: Vulnerable patients to air pollution.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(17)30052.
    PubMed     Text format     Abstract available


  271. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available


  272. BRUNETTI ND, De Gennaro L, Caldarola P, Gaglione A, et al
    Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?
    Int J Cardiol. 2017 Mar 22. pii: S0167-5273(17)31385.
    PubMed     Text format    


  273. FEMIA G, Sy RW, Puranik R
    Systematic review: Impact of the new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2017 Mar 19. pii: S0167-5273(17)30613.
    PubMed     Text format     Abstract available


  274. CAPPATO R, Ali H
    Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31691.
    PubMed     Text format     Abstract available


  275. CAMM AJ
    Hopes and disappointments with antiarrhythmic drugs.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(17)31664.
    PubMed     Text format     Abstract available


  276. TOPAZ G, Flint N, Steinvil A, Finkelstein A, et al
    Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(16)32197.
    PubMed     Text format     Abstract available


  277. GRAY B, Ingles J, Medi C, Driscoll T, et al
    Cardiovascular Effects of Energy Drinks in Familial Long QT Syndrome: A Randomized Cross-Over Study.
    Int J Cardiol. 2017;231:150-154.
    PubMed     Text format     Abstract available


  278. SCHWARTZ PJ, Dagradi F
    Red Bull(R): Red flag or red herring?
    Int J Cardiol. 2017;231:179-180.
    PubMed     Text format    


  279. LI H, Qingyao, Bingshen, Shu M, et al
    Application of 3D printing technology to left atrial appendage occlusion.
    Int J Cardiol. 2017;231:258-263.
    PubMed     Text format     Abstract available


  280. MAKOWSKI M, Smorag I, Makowska J, Bissinger A, et al
    Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)31518.
    PubMed     Text format     Abstract available


  281. BIFFI M, Ziacchi M, Ricci RP, Facchin D, et al
    Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation.
    Int J Cardiol. 2017;230:275-280.
    PubMed     Text format     Abstract available


  282. DA COSTA A, Guichard JB, Maillard N, Romeyer-Bouchard C, et al
    Substantial superiority of Niobe ES over Niobe II system in remote-controlled magnetic pulmonary vein isolation.
    Int J Cardiol. 2017;230:319-323.
    PubMed     Text format     Abstract available


  283. SUN GZ, Ye N, Chen YT, Zhou Y, et al
    Early repolarization pattern in the general population: Prevalence and associated factors.
    Int J Cardiol. 2017;230:614-618.
    PubMed     Text format     Abstract available


    February 2017
  284. FROMMEYER G, Sterneberg M, Dechering DG, Ellermann C, et al
    Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(16)33712.
    PubMed     Text format     Abstract available


  285. PROIETTI M, Lip GY
    Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
    PubMed     Text format     Abstract available


  286. HU WS, Lin CL
    CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31127.
    PubMed     Text format     Abstract available


  287. JORGENSEN TH, Thyregod HG, Tarp JB, Svendsen JH, et al
    Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31128.
    PubMed     Text format     Abstract available


  288. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  289. ANSELMINO M, Matta M, Bunch TJ, Fiala M, et al
    Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)33338.
    PubMed     Text format     Abstract available


  290. CENSI F, Calcagnini G, Mattei E, Calo L, et al
    Seasonal trends in atrial fibrillation episodes and physical activity collected daily with a remote monitoring system for cardiac implantable electronic devices.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31103.
    PubMed     Text format     Abstract available


  291. CAY S, Aras D, Topaloglu S, Ozcan F, et al
    Early repolarization syndrome and Brugada syndrome: Similar or different?
    Int J Cardiol. 2017;229:9.
    PubMed     Text format    


  292. TZIKAS A, Freixa X, Llull L, Gafoor S, et al
    Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)33705.
    PubMed     Text format     Abstract available


  293. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
    PubMed     Text format     Abstract available


  294. BADENCO N, Chong-Nguyen C, Maupain C, Himbert C, et al
    Respective role of surface electrocardiogram and His bundle recordings to assess the risk of atrioventricular block after transcatheter aortic valve replacement.
    Int J Cardiol. 2017 Feb 10. pii: S0167-5273(16)32853.
    PubMed     Text format     Abstract available


  295. MENDEZ-BAILON M, Lopez-de-Andres A, de Miguel-Diez J, de Miguel-Yanes JM, et al
    Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. An observational study using hospital discharge data in Spain (2004-2013).
    Int J Cardiol. 2017 Feb 7. pii: S0167-5273(16)34024.
    PubMed     Text format     Abstract available


  296. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
    Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
    PubMed     Text format     Abstract available


  297. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available


  298. PATEL N, Donahue C, Shenoy A, Patel A, et al
    Obstructive sleep apnea and arrhythmia: A systemic review.
    Int J Cardiol. 2017;228:967-970.
    PubMed     Text format     Abstract available


  299. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available


  300. TE AL, Lin YJ, Chen YY, Chung FP, et al
    Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up.
    Int J Cardiol. 2017;228:68-73.
    PubMed     Text format     Abstract available


  301. FROMMEYER G, Kohnke A, Ellermann C, Dechering DG, et al
    Experimental evidence for a severe proarrhythmic potential of levosimendan.
    Int J Cardiol. 2017;228:583-587.
    PubMed     Text format     Abstract available


  302. LEE G, McLellan AJ, Hunter RJ, Lovell MJ, et al
    Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.
    Int J Cardiol. 2017;228:406-411.
    PubMed     Text format     Abstract available


  303. JUNELL A, Thomas J, Hawkins L, Sklenar J, et al
    Screening entire healthcare system ECG database: Association of deep terminal negativity of P wave in lead V1 and ECG referral with mortality.
    Int J Cardiol. 2017;228:219-224.
    PubMed     Text format     Abstract available


    January 2017
  304. SWISSA M, Birk E, Dagan T, Naimer SA, et al
    Radiofrequency catheter ablation of atrioventricular node reentrant tachycardia in children with limited fluoroscopy.
    Int J Cardiol. 2017 Jan 31. pii: S0167-5273(16)34000.
    PubMed     Text format     Abstract available


  305. LIEVE KV, Verkerk AO, Podliesna S, van der Werf C, et al
    Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.
    Int J Cardiol. 2017 Jan 29. pii: S0167-5273(16)33462.
    PubMed     Text format     Abstract available


  306. ZACHARIASARDOTTIR S, Risgaard B, Agesen FN, Jabbari R, et al
    Sudden cardiac death and coronary disease in the young: A nationwide cohort study in Denmark.
    Int J Cardiol. 2017 Jan 28. pii: S0167-5273(16)33099.
    PubMed     Text format     Abstract available


  307. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Corrigendum to 'Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology' [Int. J. Cardiol. 220 (2016) 131-136].
    Int J Cardiol. 2017 Jan 27. pii: S0167-5273(17)30190.
    PubMed     Text format    


  308. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available


  309. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  310. FROMMEYER G, Kohnke A, Ellermann C, Dechering DG, et al
    Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model.
    Int J Cardiol. 2017 Jan 18. pii: S0167-5273(16)34672.
    PubMed     Text format     Abstract available


  311. LIAO YC, Chung FP, Lin YJ, Chang SL, et al
    The application of signal average ECG in the prediction of recurrences after catheter ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Int J Cardiol. 2017 Jan 18. pii: S0167-5273(16)33160.
    PubMed     Text format     Abstract available


  312. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available


  313. BANERJEE K, Ghosh RK, Kamatam S, Banerjee A, et al
    Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Int J Cardiol. 2017;227:556-564.
    PubMed     Text format     Abstract available


  314. PADALA SK, Peaslee S, Sidhu MS, Steckman DA, et al
    Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.
    Int J Cardiol. 2017;227:565-570.
    PubMed     Text format     Abstract available


  315. CHO MS, Kwon CH, Nam GB, Lee WS, et al
    Characteristics of early repolarization parameters and prognostic implications in the general ambulatory Korean population.
    Int J Cardiol. 2017;227:571-576.
    PubMed     Text format     Abstract available


  316. DA COSTA A, Axiotis A, Romeyer-Bouchard C, Abdellaoui L, et al
    Transcatheter leadless cardiac pacing: The new alternative solution.
    Int J Cardiol. 2017;227:122-126.
    PubMed     Text format     Abstract available


  317. TONDATO F, Bazzell J, Schwartz L, Mc Donald BW, et al
    Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle.
    Int J Cardiol. 2017;227:318-324.
    PubMed     Text format     Abstract available


  318. KIUCHI MG, Chen S, Purerfellner H
    Incidence of ventricular arrhythmic events in CKD patients with ICD.
    Int J Cardiol. 2017;227:312-317.
    PubMed     Text format     Abstract available


  319. KIMURA M, Fujisawa T, Aizawa Y, Matsuhashi N, et al
    An RyR2 mutation found in a family with a short-coupled variant of torsade de pointes.
    Int J Cardiol. 2017;227:367-369.
    PubMed     Text format    


  320. SEZAI A, Akahoshi T, Osaka S, Yaoita H, et al
    Sleep disordered breathing in cardiac surgery patients: The NU-SLEEP trial.
    Int J Cardiol. 2017;227:342-346.
    PubMed     Text format     Abstract available


  321. LI N, Wang Q, Sibrian-Vazquez M, Klipp RC, et al
    Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.
    Int J Cardiol. 2017;227:668-673.
    PubMed     Text format     Abstract available


  322. CHIU SN, Wu WL, Lu CW, Wu KL, et al
    Special electrophysiological characteristics of pediatric idiopathic ventricular tachycardia.
    Int J Cardiol. 2017;227:595-601.
    PubMed     Text format     Abstract available


  323. SOLARI D, Bertero E, Miceli R, Brunelli C, et al
    Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Int J Cardiol. 2017 Jan 14. pii: S0167-5273(16)33968.
    PubMed     Text format     Abstract available


  324. MCLELLAN AJ, Kumar S, Smith C, Ling LH, et al
    The role of adenosine challenge in catheter ablation for atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Jan 8. pii: S0167-5273(16)33903.
    PubMed     Text format     Abstract available


  325. DODD KW, Elm KD, Dodd EM, Smith SW, et al
    Among patients with left bundle branch block, T-wave peak to T-wave end time is prolonged in the presence of acute coronary occlusion.
    Int J Cardiol. 2017 Jan 7. pii: S0167-5273(16)32444.
    PubMed     Text format     Abstract available


  326. HANON O, Vidal JS, Le Heuzey JY, Kirchhof P, et al
    Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.
    Int J Cardiol. 2017 Jan 7. pii: S0167-5273(17)30078.
    PubMed     Text format     Abstract available


  327. MESQUITA J, Cavaco D, Ferreira A, Lopes N, et al
    Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30065.
    PubMed     Text format     Abstract available


  328. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30072.
    PubMed     Text format     Abstract available


  329. FENG Y, Liu J, Wang M, Liu M, et al
    The E23K variant of the Kir6.2 subunit of the ATP-sensitive potassium channel increases susceptibility to ventricular arrhythmia in response to ischemia in rats.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(17)30041.
    PubMed     Text format     Abstract available


  330. MAURIZI N, Tanini I, Olivotto I, Amendola E, et al
    Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(16)33706.
    PubMed     Text format     Abstract available


  331. BASILI S, Loffredo L, Pastori D, Proietti M, et al
    Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(16)33242.
    PubMed     Text format     Abstract available


  332. CHANAVIRUT R, Tong-Un T, Jirakulsomchok D, Wyss JM, et al
    Abnormal autonomic nervous system function in rural Thai men: A potential contributor to their high risk of sudden unexplained nocturnal death syndrome.
    Int J Cardiol. 2017;226:87-92.
    PubMed     Text format     Abstract available


    December 2016
  333. YOUNES A, Al-Kindi SG, Alajaji W, Mackall JA, et al
    Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32654.
    PubMed     Text format     Abstract available


  334. NEEFS J, van den Berg NW, Limpens J, Berger WR, et al
    Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Int J Cardiol. 2016 Dec 23. pii: S0167-5273(16)32577.
    PubMed     Text format     Abstract available


  335. GOUDIS CA, Ketikoglou DG
    Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications.
    Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34611.
    PubMed     Text format     Abstract available


  336. SIMANTIRAKIS EN, Papakonstantinou PE, Chlouverakis GI, Kanoupakis EM, et al
    Asymptomatic versus symptomatic episodes in patients with paroxysmal atrial fibrillation via long-term monitoring with implantable loop recorders.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)33814.
    PubMed     Text format     Abstract available


  337. YANG PS, Kim TH, Uhm JS, Kim JY, et al
    Clinical characteristics of complex aortic plaque in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34564.
    PubMed     Text format     Abstract available


  338. LIU JC, Wang TJ, Sung LC, Kao PF, et al
    Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: A population-based cohort study.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34563.
    PubMed     Text format     Abstract available


  339. BERTEL N, Witassek F, Puhan M, Erne P, et al
    Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34533.
    PubMed     Text format     Abstract available


  340. SAFAK E, D'Ancona G, Ince H
    Reply to "Don't throw the baby out with the bathwater: Appropriate or inappropriate shocks after implantable cardioverter-defibrillator".
    Int J Cardiol. 2016 Dec 13. pii: S0167-5273(16)34256.
    PubMed     Text format    


  341. DUYGU H
    Galectin-3 and atrial fibrillation.
    Int J Cardiol. 2016 Dec 8. pii: S0167-5273(16)33915.
    PubMed     Text format    


  342. SVERDLOV AL, Ngo DT
    Response to the letter to editor: Galectin-3 and atrial fibrillation.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34243.
    PubMed     Text format    


  343. CERIT L
    Prediction of thromboembolic events for patients with non-valvular atrial fibrillation; CHA2DS2-VASc-UA2-VitD.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34060.
    PubMed     Text format    


  344. HE H, Guo J
    Response to the letter to editor: Prediction of thromboembolic events for patients with non-valvular atrial fibrillation CHA2DS2-VASc-UA2-VitD.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34248.
    PubMed     Text format    


  345. LI N, Dobrev D
    Hyperuricemia: A causal player or a bystander linking inflammatory signaling and atrial fibrillation?
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34221.
    PubMed     Text format    


  346. ANDO G, Capranzano P
    Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis.
    Int J Cardiol. 2016 Dec 2. pii: S0167-5273(16)32808.
    PubMed     Text format     Abstract available


    November 2016
  347. LOU B, Gao H, Zhou C
    Remote ischemic preconditioning reduces the recurrence of atrial fibrillation after ablation: Essentially influential factors need to be adjusted.
    Int J Cardiol. 2016 Nov 19. pii: S0167-5273(16)33536.
    PubMed     Text format    


  348. LEE CH, Lin TY, Chang SH, Chen CH, et al
    Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Int J Cardiol. 2016;228:771-778.
    PubMed     Text format     Abstract available


  349. JACOB KA, Buijsrogge MP, Frencken JF, Ten Berg MJ, et al
    White blood cell count and new-onset atrial fibrillation after cardiac surgery.
    Int J Cardiol. 2016;228:971-976.
    PubMed     Text format     Abstract available


  350. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Text format     Abstract available


  351. LIU T, Shao Q, Korantzopoulos P, Miao S, et al
    Relation of red blood cell distribution width with CHADS2 and CHA2DS2-VASc score in Chinese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016;228:861-864.
    PubMed     Text format     Abstract available


  352. KOSIUK J, Hilbert S, John S, Bertagnolli L, et al
    Preliminary experience with high-density electroanatomical mapping for ablation of atrial fibrillation - Comparison of mini-basket and novel open irrigated magnetic ablation catheter in consecutive patients.
    Int J Cardiol. 2016;228:401-405.
    PubMed     Text format     Abstract available


  353. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  354. TAKAOKA H, Funabashi N, Ozawa K, Uehara M, et al
    Computed tomography is important in appropriately diagnosing patients with third-degree atrioventricular block and second-degree atrioventricular block but not Wenckebach type.
    Int J Cardiol. 2016;228:700-706.
    PubMed     Text format     Abstract available


  355. CAPUTO ML, Regoli F, Conte G, Adjibodou B, et al
    Temporal trends and long term follow-up of implantable cardioverter defibrillator therapy for secondary prevention: A 15-year single-centre experience.
    Int J Cardiol. 2016;228:31-36.
    PubMed     Text format     Abstract available


  356. DE SOUZA MV, de Fatima Dos Santos Teixeira P, Vaisman M, Xavier SS, et al
    Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation.
    Int J Cardiol. 2016;228:919-925.
    PubMed     Text format     Abstract available


  357. CHOU RH, Lo LW, Liou YJ, Shu JH, et al
    Antipsychotic treatment is associated with risk of atrial fibrillation: A nationwide nested case-control study.
    Int J Cardiol. 2016;227:134-140.
    PubMed     Text format     Abstract available


  358. RUSSELL EA, Walsh WF, Tran L, Tam R, et al
    The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients.
    Int J Cardiol. 2016;227:100-105.
    PubMed     Text format     Abstract available


  359. LEIBOWITZ D, Abitbol C, Alcalai R, Rivkin G, et al
    Perioperative atrial fibrillation is associated with increased one-year mortality in elderly patients after repair of hip fracture.
    Int J Cardiol. 2016;227:58-60.
    PubMed     Text format     Abstract available


  360. NISHIYAMA T, Tanosaki S, Tanaka M, Yanagisawa R, et al
    Predictive factor and clinical consequence of left bundle-branch block after a transcatheter aortic valve implantation.
    Int J Cardiol. 2016;227:25-29.
    PubMed     Text format     Abstract available


  361. ZHAO LQ, Zhang GB, Wen ZJ, Huang CK, et al
    Common variants predict recurrence after nonfamilial atrial fibrillation ablation in Chinese Han population.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33504.
    PubMed     Text format     Abstract available


  362. WANG YS, Chen GY, Li XH, Zhou X, et al
    Prolonged P-wave duration is associated with atrial fibrillation recurrence after radiofrequency catheter ablation: A systematic review and meta-analysis.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33500.
    PubMed     Text format     Abstract available


  363. GUERRA F, Romandini A, Barbarossa A, Belardinelli L, et al
    Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33562.
    PubMed     Text format     Abstract available


  364. ZHU W, Fu L, Ding Y, Huang L, et al
    Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
    PubMed     Text format     Abstract available


  365. TAKIGAWA M, Takahashi A, Kuwahara T, Okubo K, et al
    Long-term outcome after catheter ablation of paroxysmal atrial fibrillation: Impact of different atrial fibrillation foci.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33474.
    PubMed     Text format     Abstract available


  366. PAPAGEORGIOU N, Providencia R, Srinivasan N, Bronis K, et al
    Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.
    Int J Cardiol. 2016;227:151-160.
    PubMed     Text format     Abstract available


  367. PHILLIPS KP, Walker DT
    Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation.
    Int J Cardiol. 2016;228:865-869.
    PubMed     Text format     Abstract available


  368. WU SH, Qin M, Jiang WF, Wang YL, et al
    A clinical study on the electrophysiological characteristics of patients without recurrence after ablation of persistent atrial fibrillation.
    Int J Cardiol. 2016;228:853-860.
    PubMed     Text format     Abstract available


  369. PONTONE G, Andreini D, Petulla M, Annoni A, et al
    Left atrium and pulmonary vein imaging using sub-millisiviert cardiac computed tomography: Impact on radiofrequency catheter ablation cumulative radiation exposure and outcome in atrial fibrillation patients.
    Int J Cardiol. 2016;228:805-811.
    PubMed     Text format     Abstract available


  370. NAKAMURA K, Naito S, Kaseno K, Nakatani Y, et al
    Integration of intracardiac echocardiography and computed tomography during atrial fibrillation ablation: Combining ultrasound contours obtained from the right atrium and ventricular outflow tract.
    Int J Cardiol. 2016;228:677-686.
    PubMed     Text format     Abstract available


  371. LIN CY, Chung FP, Lin YJ, Chang SL, et al
    Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33499.
    PubMed     Text format     Abstract available


  372. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


  373. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


  374. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
    Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
    PubMed     Text format     Abstract available


  375. YANG CH, Chou CC, Hung KC, Wen MS, et al
    Comparisons of the underlying mechanisms of left atrial remodeling after repeat circumferential pulmonary vein isolation with or without additional left atrial linear ablation in patients with recurrent atrial fibrillation.
    Int J Cardiol. 2016;228:449-455.
    PubMed     Text format     Abstract available


  376. HONARBAKHSH S, Providencia R, Srinivasan N, Ahsan S, et al
    A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Int J Cardiol. 2016;228:280-285.
    PubMed     Text format     Abstract available


  377. FROMMEYER G, Puckhaber D, Ellermann C, Dechering DG, et al
    Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone.
    Int J Cardiol. 2016;228:74-79.
    PubMed     Text format     Abstract available


  378. WITKOWSKI M, Bissinger A, Grycewicz T, Lubinski A, et al
    Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker.
    Int J Cardiol. 2016 Nov 5. pii: S0167-5273(16)33302.
    PubMed     Text format     Abstract available


  379. ALLAMSETTY S, Lo LW, Lin YJ, Chang SL, et al
    Impact of aortic encroachment to left atrium on non-pulmonary vein triggers of atrial fibrillation.
    Int J Cardiol. 2016 Nov 1. pii: S0167-5273(16)33269.
    PubMed     Text format     Abstract available


    October 2016
  380. SANCHIS-GOMAR F, Perez-Quilis C, Lippi G, Cervellin G, et al
    Atrial fibrillation in highly trained endurance athletes - Description of a syndrome.
    Int J Cardiol. 2016;226:11-20.
    PubMed     Text format     Abstract available


  381. CERIT L
    Don't throw the baby out with the bathwater: Appropriate or inappropriate shocks after implantable cardioverter-defibrillator.
    Int J Cardiol. 2016 Oct 13. pii: S0167-5273(16)32388.
    PubMed     Text format    


  382. MARTINEZ-ALANIS M, Ruiz-Velasco S, Lerma C
    Quantitative analysis of ventricular ectopic beats in short-term RR interval recordings to predict imminent ventricular tachyarrhythmia.
    Int J Cardiol. 2016;225:226-233.
    PubMed     Text format     Abstract available


  383. ZHAO L, Xu K, Jiang W, Zhou L, et al
    Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement.
    Int J Cardiol. 2016;225:82-86.
    PubMed     Text format     Abstract available


  384. ANDO G, Trio O
    New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation.
    Int J Cardiol. 2016;225:244-246.
    PubMed     Text format    


    September 2016
  385. VAN DEN BERG NW, Slieker MG, van Beynum IM, Bilardo CM, et al
    Fluorinated steroids do not improve outcome of isolated atrioventricular block.
    Int J Cardiol. 2016;225:167-171.
    PubMed     Text format     Abstract available


  386. BROWN LA, Boos CJ
    Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32512.
    PubMed     Text format     Abstract available


  387. LIN WL, Lo LW, Chen HR, Lai CT, et al
    Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction.
    Int J Cardiol. 2016;225:65-72.
    PubMed     Text format     Abstract available


  388. MARZONA I, Vannini T, Roncaglioni MC, Tettamanti M, et al
    Response to " Dementia and death: Separate sides of the same Atrial Fibrillation coin?"
    Int J Cardiol. 2016 Sep 28. pii: S0167-5273(16)32566.
    PubMed     Text format    


  389. CHANG Q, Liu R
    Atrioventricular dissociation with QRS complex change in the atrioventricular block: What are the degree and the site of block?
    Int J Cardiol. 2016;225:215-217.
    PubMed     Text format    


  390. BADHWAR N, Mittal S, Rasekh A, Vasaiwala S, et al
    Conversion of persistent atrial fibrillation to sinus rhythm after LAA ligation with the LARIAT device.
    Int J Cardiol. 2016;225:120-122.
    PubMed     Text format    


  391. GARG L, Garg J, Gupta N, Shah N, et al
    Gastrointestinal complications associated with catheter ablation for atrial fibrillation.
    Int J Cardiol. 2016;224:424-430.
    PubMed     Text format     Abstract available


  392. KIUCHI MG, Chen S
    Renal sympathetic stimulation in patients with controlled hypertension and paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;224:394-397.
    PubMed     Text format    


  393. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  394. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  395. WONGCHAROEN W, Ruttanaphol A, Gunaparn S, Phrommintikul A, et al
    Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;224:252-255.
    PubMed     Text format     Abstract available


  396. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
    A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Int J Cardiol. 2016;224:454-455.
    PubMed     Text format    


  397. CAMINITI G, Fossati C, Rosano G, Volterrani M, et al
    Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77].
    Int J Cardiol. 2016 Sep 7. pii: S0167-5273(16)32050.
    PubMed     Text format    


    August 2016
  398. ARAMBULA-GARZA E, Castillo-Martinez L, Gonzalez-Islas D, Orea-Tejeda A, et al
    Association of cardiac cachexia and atrial fibrillation in heart failure patients.
    Int J Cardiol. 2016;223:863-866.
    PubMed     Text format     Abstract available


  399. KOSIUK J, Lindemann F, Hindricks G, Bollmann A, et al
    Need for further studies on ivabradine in patients with persistent atrial fibrillation.
    Int J Cardiol. 2016;223:915-916.
    PubMed     Text format    


  400. KOBAYASHI N, Yamawaki M, Nakano M, Hirano K, et al
    A new scoring system (DAIGA) for predicting bleeding complications in atrial fibrillation patients after drug-eluting stent implantation with triple antithrombotic therapy.
    Int J Cardiol. 2016;223:985-991.
    PubMed     Text format     Abstract available


  401. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study.
    Int J Cardiol. 2016;223:829-837.
    PubMed     Text format     Abstract available


  402. LEE SR, Choi EK, Rhee TM, Lee HJ, et al
    Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2016;223:953-957.
    PubMed     Text format     Abstract available


  403. DESTEGHE L, Engelhard L, Raymaekers Z, Kluts K, et al
    Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire.
    Int J Cardiol. 2016;223:906-914.
    PubMed     Text format     Abstract available


  404. WOLTERS FJ, Rizopoulos D, Ikram MA
    Dementia and death: Separate sides of the atrial fibrillation coin?
    Int J Cardiol. 2016 Aug 20. pii: S0167-5273(16)31962.
    PubMed     Text format    


  405. ALGHAMRY A, Hanna J, Pelecanos A, Kyranis S, et al
    Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure.
    Int J Cardiol. 2016;223:744-749.
    PubMed     Text format     Abstract available


  406. PASTORI D, Pignatelli P, Perticone F, Sciacqua A, et al
    Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
    Int J Cardiol. 2016;223:619-624.
    PubMed     Text format     Abstract available


  407. OH S, Goto S, Accetta G, Angchaisuksiri P, et al
    Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry.
    Int J Cardiol. 2016;223:543-547.
    PubMed     Text format     Abstract available


  408. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Text format     Abstract available


  409. HASEGAWA K, Watanabe H, Hisamatsu T, Ohno S, et al
    Early repolarization and risk of arrhythmia events in long QT syndrome.
    Int J Cardiol. 2016;223:540-542.
    PubMed     Text format    


  410. CHEN D, Procter N, Goh V, Liu S, et al
    New onset atrial fibrillation is associated with elevated galectin-3 levels.
    Int J Cardiol. 2016;223:48-49.
    PubMed     Text format    


  411. BIERNACKA KE, Kukla P, Dubowski K, Wozniak O, et al
    Early repolarization in patients with arrhythmogenic right ventricular cardiomyopathy is not frequent phenomenon.
    Int J Cardiol. 2016;222:982-983.
    PubMed     Text format    


  412. ERGUN G, Dogan V, Basaran O, Biteker M, et al
    Metoprolol vs ivabradine in patients with mitral stenosis.
    Int J Cardiol. 2016;223:108.
    PubMed     Text format    


  413. NAGRA B, Awan MU, Miriyala V, Kantharia BK, et al
    Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Int J Cardiol. 2016;222:978-979.
    PubMed     Text format    


  414. SAFAK E, D'Ancona G, Ince H
    Inappropriate shocks after implantable cardioverter-defibrillator for primary prevention in idiopathic cardiomyopathy: Independent determinants.
    Int J Cardiol. 2016;223:512-513.
    PubMed     Text format    


  415. WONG CW, Chan YH, Cheng YH, Lam CS, et al
    Is overwork a precipitant factor of idiopathic ventricular fibrillation?
    Int J Cardiol. 2016;223:218-219.
    PubMed     Text format    


  416. AKIMA T, Koyama T, Munakata M, Shibata M, et al
    Absence of reperfusion-induced arrhythmia in patients with ST-segment elevation myocardial infarction treated using postconditioning with lactate-enriched blood.
    Int J Cardiol. 2016;222:780-781.
    PubMed     Text format    


  417. SANI M, Ayubi E, Mansori K, Khazaei S, et al
    Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
    Int J Cardiol. 2016;222:949.
    PubMed     Text format    


  418. FEDELI U, Ferroni E, Pengo V
    Mortality associated to atrial fibrillation still on the rise: United States, 1999 to 2014.
    Int J Cardiol. 2016;222:788-789.
    PubMed     Text format    


  419. SHUAI W, Wang XX, Hong K, Peng Q, et al
    How to estimate heart rate from pulse rate reported by oscillometric method in atrial fibrillation: The value of pulse rate variation.
    Int J Cardiol. 2016;222:1022-1026.
    PubMed     Text format     Abstract available


  420. LU Y, Li K, Liu XS, Zhang N, et al
    Ivabradine and atrial fibrillation: A double-edged sword.
    Int J Cardiol. 2016;223:182-185.
    PubMed     Text format    


  421. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
    Oral anticoagulation in octogenarians with atrial fibrillation.
    Int J Cardiol. 2016;223:87-90.
    PubMed     Text format     Abstract available


  422. LEE HC, Chiu CC, Chen CC, Huang JW, et al
    Modulation of potassium channel KCNQ1 transcript in right atrial appendage of patients with postoperative atrial fibrillation.
    Int J Cardiol. 2016;222:696-698.
    PubMed     Text format    


  423. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
    Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
    PubMed     Text format     Abstract available


  424. SVENNBERG E, Lindahl B, Berglund L, Eggers KM, et al
    NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Int J Cardiol. 2016;223:74-81.
    PubMed     Text format     Abstract available


  425. ALEXANDER B, Rodriguez C, de la Isla LP, Islas F, et al
    The impact of advanced Interatrial block on new-onset atrial fibrillation following TAVR procedure.
    Int J Cardiol. 2016;223:672-673.
    PubMed     Text format    


  426. HOSSEINI S, Rezaei Y, Samiei N, Emkanjoo Z, et al
    Effects of mitral valve repair on ventricular arrhythmia in patients with mitral valve prolapse syndrome: A report of two cases.
    Int J Cardiol. 2016;222:603-605.
    PubMed     Text format    


  427. KIM Y, Lee SH
    Embolic stroke and after-admission atrial fibrillation.
    Int J Cardiol. 2016;222:576-580.
    PubMed     Text format     Abstract available


  428. YAO T, Tanaka K, Fujimura T, Murayama K, et al
    Plasma levels of oxidative stress-responsive apoptosis inducing protein (ORAIP) in patients with atrial fibrillation.
    Int J Cardiol. 2016;222:528-530.
    PubMed     Text format    


  429. BEDEIR K, Giugliano RP, Ramlawi B
    Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Int J Cardiol. 2016;222:615-619.
    PubMed     Text format     Abstract available


  430. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
    Obesity and atrial fibrillation.
    Int J Cardiol. 2016;223:159-160.
    PubMed     Text format    


  431. AGRAWAL S, Garg L, Nanda S, Sharma A, et al
    The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis.
    Int J Cardiol. 2016;222:379-384.
    PubMed     Text format     Abstract available


  432. CORTEZ-DIAS N, Costa MC, de Sousa J, Fiuza M, et al
    Expanding the functional role of miRNAs in the establishment of permanent atrial fibrillation.
    Int J Cardiol. 2016;222:340-341.
    PubMed     Text format    


  433. HAMON D, Algalarrondo V, Gandjbakhch E, Extramiana F, et al
    Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.
    Int J Cardiol. 2016;222:562-568.
    PubMed     Text format     Abstract available


    July 2016
  434. HAN R, Liu X, Yin X, Zheng M, et al
    Effect of remote ischemic preconditioning on myocardial injury and inflammatory response induced by ablation for atrial fibrillation: A randomized controlled trial.
    Int J Cardiol. 2016;222:396-400.
    PubMed     Text format     Abstract available


  435. BAHRAINY S, Levy WC, Busey JM, Caldwell JH, et al
    Exercise training bradycardia is largely explained by reduced intrinsic heart rate.
    Int J Cardiol. 2016;222:213-216.
    PubMed     Text format     Abstract available


  436. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
    Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
    Int J Cardiol. 2016;223:63-64.
    PubMed     Text format    


  437. ABDUL-KADIR NA, Mat Safri N, Othman MA
    Atrial fibrillation classification and association between the natural frequency and the autonomic nervous system.
    Int J Cardiol. 2016;222:504-508.
    PubMed     Text format     Abstract available


  438. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
    Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
    Int J Cardiol. 2016;222:430-435.
    PubMed     Text format     Abstract available


  439. ZHU W, Guo L, Hong K
    Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review.
    Int J Cardiol. 2016;222:289-294.
    PubMed     Text format     Abstract available


  440. TSAI FC, Lin YC, Chang SH, Chang GJ, et al
    Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis.
    Int J Cardiol. 2016;222:104-112.
    PubMed     Text format     Abstract available


  441. HE H, Guo J, Zhang A
    The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016;221:827-830.
    PubMed     Text format     Abstract available


  442. BARBOSA MP, da Costa Rocha MO, Neto ES, Brandao FV, et al
    Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Int J Cardiol. 2016;222:80-85.
    PubMed     Text format     Abstract available


  443. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Int J Cardiol. 2016;221:789-793.
    PubMed     Text format     Abstract available


  444. MADIAS JE
    "Single beat only" recovery from stable left bundle branch block, engendered by an atrial premature beat.
    Int J Cardiol. 2016;221:770-771.
    PubMed     Text format    


  445. GARG L, Chen C, Haines DE
    Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
    Int J Cardiol. 2016;222:47-50.
    PubMed     Text format     Abstract available


  446. BRUNETTI ND, Santoro F, Correale M, De Gennaro L, et al
    Incidence of atrial fibrillation is associated with age and gender in subjects practicing physical exercise: A meta-analysis and meta-regression analysis.
    Int J Cardiol. 2016;221:1056-1060.
    PubMed     Text format     Abstract available


  447. CABRERA S, Valles E, Benito B, Alcalde O, et al
    Simple predictors for new onset atrial fibrillation.
    Int J Cardiol. 2016;221:515-520.
    PubMed     Text format     Abstract available


  448. SENOO K, Lip GY
    Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
    Int J Cardiol. 2016;221:379-382.
    PubMed     Text format     Abstract available


  449. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available


  450. KORNEJ J, Ueberham L, Schmidl J, Husser D, et al
    Addition of TGF-beta1 to existing clinical risk scores does not improve prediction for arrhythmia recurrences after catheter ablation of atrial fibrillation.
    Int J Cardiol. 2016;221:52-54.
    PubMed     Text format    


  451. WO HT, Liao FC, Chang PC, Chou CC, et al
    Circumferential ablation at the base of the left ventricular papillary muscles: A highly effective approach for ventricular arrhythmias originating from the papillary muscles.
    Int J Cardiol. 2016;220:876-882.
    PubMed     Text format     Abstract available


  452. SAIRAKU A, Yoshida Y, Nakano Y, Hirayama H, et al
    Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Int J Cardiol. 2016;221:597-600.
    PubMed     Text format     Abstract available


    June 2016
  453. FUENMAYOR AJ, Rodriguez FJ, Gutierrez MD
    Successful catheter ablation in a patient with Scimitar and Wolff-Parkinson-White syndromes.
    Int J Cardiol. 2016;221:1048-1050.
    PubMed     Text format    


  454. HONG-TAOYUAN, Yang M, Zhong L, Lee YH, et al
    Ventricular premature contraction associated with mitral valve prolapse.
    Int J Cardiol. 2016;221:1144-1149.
    PubMed     Text format     Abstract available


  455. HERMES IL, Marianna GS, Jessica RC, Carlos BR, et al
    Development and validation of a risk calculator predicting exercise-induced ventricular arrhythmia in patients with cardiovascular disease.
    Int J Cardiol. 2016;220:625-628.
    PubMed     Text format     Abstract available


  456. ZAMAN JA, Harling L, Ashrafian H, Darzi A, et al
    Post-operative atrial fibrillation is associated with a pre-existing structural and electrical substrate in human right atrial myocardium.
    Int J Cardiol. 2016;220:580-588.
    PubMed     Text format     Abstract available


  457. CAMELI M, Mandoli GE, Loiacono F, Sparla S, et al
    Left atrial strain: A useful index in atrial fibrillation.
    Int J Cardiol. 2016;220:208-213.
    PubMed     Text format     Abstract available


  458. MARZONA I, Baviera M, Vannini T, Tettamanti M, et al
    Risk of dementia and death in patients with atrial fibrillation: A competing risk analysis of a population-based cohort.
    Int J Cardiol. 2016;220:440-444.
    PubMed     Text format     Abstract available


  459. GOSTOLI S, Bonomo M, Roncuzzi R, Biffi M, et al
    Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD).
    Int J Cardiol. 2016;220:360-364.
    PubMed     Text format     Abstract available


  460. BEGG GA, Holden AV, Lip GY, Plein S, et al
    Assessment of atrial fibrosis for the rhythm control of atrial fibrillation.
    Int J Cardiol. 2016;220:155-161.
    PubMed     Text format     Abstract available


  461. CHOI EJ, Lee IH, Je NK
    Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
    Int J Cardiol. 2016;220:647-652.
    PubMed     Text format     Abstract available


  462. LANDSTROM AP, Boczek NJ, Ye D, Miyake CY, et al
    Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
    Int J Cardiol. 2016;220:290-298.
    PubMed     Text format     Abstract available


  463. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available


  464. DE GENNARO L, Brunetti ND, Resta M, Rutigliano D, et al
    Cardiac arrest and ventricular fibrillation in a young man treated with capecitabine: Case report and literature review.
    Int J Cardiol. 2016;220:280-283.
    PubMed     Text format    


  465. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.
    Int J Cardiol. 2016;220:131-136.
    PubMed     Text format     Abstract available


  466. BREMBILLA-PERROT B, Olivier A, Villemin T, Vincent J, et al
    Prediction of atrial fibrillation in patients with supraventricular tachyarrhythmias treated with catheter ablation or not. Classical scores are not useful.
    Int J Cardiol. 2016;220:102-106.
    PubMed     Text format     Abstract available


  467. WILSON DG, Leventigiannis G, Barr C, Morgan JM, et al
    ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators.
    Int J Cardiol. 2016;220:27-31.
    PubMed     Text format     Abstract available


  468. SHALI S, Su Y, Ge J
    Interatrial septal pacing to suppress atrial fibrillation in patients with dual chamber pacemakers: A meta-analysis of randomized, controlled trials.
    Int J Cardiol. 2016;219:421-427.
    PubMed     Text format     Abstract available


  469. ZHAO YJ, Lin L, Zhou HJ, Tan KT, et al
    Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation.
    Int J Cardiol. 2016;220:794-801.
    PubMed     Text format     Abstract available


  470. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
    Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
    PubMed     Text format     Abstract available


  471. BELGAID DR, Khan Z, Zaidi M, Hobbs A, et al
    Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial.
    Int J Cardiol. 2016;219:177-179.
    PubMed     Text format     Abstract available


  472. AVILA P, Marcotte F, Dore A, Mercier LA, et al
    The impact of exercise on ventricular arrhythmias in adults with tetralogy of Fallot.
    Int J Cardiol. 2016;219:218-224.
    PubMed     Text format     Abstract available


  473. CHENG WL, Kao YH, Chen SA, Chen YJ, et al
    Pathophysiology of cancer therapy-provoked atrial fibrillation.
    Int J Cardiol. 2016;219:186-194.
    PubMed     Text format     Abstract available


  474. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
    Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Int J Cardiol. 2016;219:251-256.
    PubMed     Text format     Abstract available


    May 2016
  475. PETERS S
    The history of Brugada syndrome -- Continuum with arrhythmogenic cardiomyopathy or lone disease?
    Int J Cardiol. 2016;211:84-5.
    PubMed     Text format    


  476. VELOSO HH
    Why should we abort the expression 'aborted sudden death'.
    Int J Cardiol. 2016;211:67.
    PubMed     Text format    


  477. ZHU W, Yuan P, Shen Y, Wan R, et al
    Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies.
    Int J Cardiol. 2016;218:259-266.
    PubMed     Text format     Abstract available


  478. GARG J, Chaudhary R, Krishnamoorthy P, Palaniswamy C, et al
    Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials.
    Int J Cardiol. 2016;218:235-239.
    PubMed     Text format     Abstract available


  479. PENG L, Li S, Tang X, Luo Y, et al
    The prognostic value of exercise-induced ventricular arrhythmias in patients with and without coronary artery disease: A meta-analysis.
    Int J Cardiol. 2016;218:225-232.
    PubMed     Text format     Abstract available


  480. PHAN K, Khuong JN, Xu J, Kanagaratnam A, et al
    Obesity and postoperative atrial fibrillation in patients undergoing cardiac surgery: Systematic review and meta-analysis.
    Int J Cardiol. 2016;217:49-57.
    PubMed     Text format     Abstract available


  481. FAUCHIER L, Chaize G, Gaudin AF, Vainchtock A, et al
    Predictive ability of HAS-BLED, HEMORRHAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.
    Int J Cardiol. 2016;217:85-91.
    PubMed     Text format     Abstract available


  482. GARCIA-FERNANDEZ A, Marin F, Roldan V, Galcera-Jornet E, et al
    The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
    Int J Cardiol. 2016;217:42-48.
    PubMed     Text format     Abstract available


  483. THAKAR S, Koshkelashvili N, Bucay MJ, Lichstein E, et al
    Electrocardiographic changes in patients >/= 100 years of age.
    Int J Cardiol. 2016;210:156-7.
    PubMed     Text format    


  484. KAO YH, Hsu JC, Chen YC, Lin YK, et al
    ZFHX3 knockdown increases arrhythmogenesis and dysregulates calcium homeostasis in HL-1 atrial myocytes.
    Int J Cardiol. 2016;210:85-92.
    PubMed     Text format     Abstract available


  485. DENDRAMIS G
    Brugada syndrome and Brugada phenocopy. The importance of a differential diagnosis.
    Int J Cardiol. 2016;210:25-7.
    PubMed     Text format     Abstract available


  486. BORNAUN H, Oztarhan K, Ocak Z, Ekiz A, et al
    Contribution of TGFB1 and TNF-alpha genes in one of twin pregnancies with congenital complete heart block phenotype.
    Int J Cardiol. 2016;210:16-8.
    PubMed     Text format    


    April 2016
  487. BOSSEAU C, Donal E
    Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients.
    Int J Cardiol. 2016 Apr 22. pii: S0167-5273(16)30278.
    PubMed     Text format    


  488. SHUAI W, Wang XX, Hong K, Peng Q, et al
    Is 10-second electrocardiogram recording enough for accurately estimating heart rate in atrial fibrillation.
    Int J Cardiol. 2016;215:175-178.
    PubMed     Text format     Abstract available


  489. PROIETTI M, Lane DA, Lip GY
    Relation of the SAMe-TTR score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
    Int J Cardiol. 2016;216:168-172.
    PubMed     Text format     Abstract available


  490. SIMANTIRAKIS E, Marketou M, Kehagias E, Kanoupakis E, et al
    Symptomatic exercise-induced complete atrioventricular block due to severe superior vena cava stenosis.
    Int J Cardiol. 2016;215:167-168.
    PubMed     Text format    


  491. MODESTI PA, Colella A, Zhao D
    Atrial fibrillation in first generation Chinese migrants living in Europe: A proof of concept study.
    Int J Cardiol. 2016;215:269-272.
    PubMed     Text format     Abstract available


  492. HU XL, Chen Y, Zhou ZD, Ying J, et al
    Posterior pericardiotomy for the prevention of atrial fibrillation after coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;215:252-256.
    PubMed     Text format     Abstract available


  493. STOLLBERGER C, Finsterer J, Schneider B
    Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
    Int J Cardiol. 2016;216:186-187.
    PubMed     Text format    


  494. WIECZOREK J, Mizia-Stec K, Lasek-Bal A, Wieczorek P, et al
    CHA2DS2-Vasc score, age and body mass index as the main risk factors of hyperintense brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation.
    Int J Cardiol. 2016;215:476-481.
    PubMed     Text format     Abstract available


  495. NISHI T, Takaoka H, Funabashi N, Nishimura M, et al
    Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping.
    Int J Cardiol. 2016;209:248-52.
    PubMed     Text format    


  496. HAMMOND-HALEY M, Patel RS, Providencia R, Lambiase PD, et al
    Exercise restrictions for patients with inherited cardiac conditions: Current guidelines, challenges and limitations.
    Int J Cardiol. 2016;209:234-41.
    PubMed     Text format     Abstract available


  497. ZUCCHELLI G, Soldati E, Segreti L, Di Cori A, et al
    Incessant accelerated idioventricular rhythm in pregnancy: An unusual long lasting case.
    Int J Cardiol. 2016;209:151-2.
    PubMed     Text format    


  498. ALKHOULI M, Sarraf M, Zack CJ, Holmes DR, et al
    Iatrogenic atrial septal defect following transseptal cardiac interventions.
    Int J Cardiol. 2016;209:142-8.
    PubMed     Text format     Abstract available


  499. LIU R, Chang Q, Liu A
    Permanent atrial fibrillation: Special electrocardiogram in hyperkalemia.
    Int J Cardiol. 2016;215:519-520.
    PubMed     Text format    


  500. KANG SH, Choi EK, Han KD, Lee SR, et al
    Underweight is a risk factor for atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2016;215:449-456.
    PubMed     Text format     Abstract available


  501. PETERS S
    Proof of an association between Morbus Ebstein and arrhythmogenic cardiomyopathy in a patient with chronic atrial fibrillation.
    Int J Cardiol. 2016;215:436-437.
    PubMed     Text format    


  502. SJALANDER S, Svensson PJ, Friberg L
    Atrial fibrillation patients with CHADS-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Int J Cardiol. 2016;215:360-363.
    PubMed     Text format     Abstract available


  503. JOHNSON SM, Brophy JM
    Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation.
    Int J Cardiol. 2016;214:502-507.
    PubMed     Text format     Abstract available


  504. JIE Q, Wang D, Liu B, Zhao D, et al
    Does left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?
    Int J Cardiol. 2016;215:494-501.
    PubMed     Text format     Abstract available


  505. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


  506. MAEDA R, Minami Y, Haruki S, Kanbayashi K, et al
    Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Int J Cardiol. 2016;214:419-422.
    PubMed     Text format     Abstract available


  507. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
    Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
    Int J Cardiol. 2016;215:11-13.
    PubMed     Text format    


  508. ZIAEI F, Zaman M, Rasoul D, Gorantla RS, et al
    The prevalence of atrial fibrillation amongst heart failure patients increases with age.
    Int J Cardiol. 2016;214:410-411.
    PubMed     Text format    


  509. OZEKE O, Edipoglu E, Karakurt M, Karabulut O, et al
    Association of ST elevation with not only post-infarction ischemic apical aneurysm but also apical aneurysm associated with hypertrophic cardiomyopathy.
    Int J Cardiol. 2016;208:92-4.
    PubMed     Text format    


  510. EGBE AC, Connolly HM, Niaz T, McLeod CJ, et al
    Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients.
    Int J Cardiol. 2016;208:115-9.
    PubMed     Text format     Abstract available


  511. MELOCHE J, Gottschalk BH, Boles U, LaHaye S, et al
    Hypophosphatemia as a novel etiology of Brugada Phenocopy.
    Int J Cardiol. 2016;208:70-1.
    PubMed     Text format    


  512. DE REGIBUS V, Rordorf R, Giorgianni C, Canclini C, et al
    Autosomal recessive atrial disease presenting with sick sinus syndrome (SSS), right atrial fibrosis and biatrial dilatation: Clinical impact of genetic diagnosis.
    Int J Cardiol. 2016;208:67-9.
    PubMed     Text format    


    March 2016
  513. XIANG R, Fan LL, Huang H, Zhao SP, et al
    Whole-exome sequencing identifies a novel mutation of DSG2 (Y198C) in a Chinese arrhythmogenic right ventricular cardiomyopathy patient.
    Int J Cardiol. 2016;214:1-3.
    PubMed     Text format    


  514. PETERS S
    Electrocardiographic morphology in right precordial T waves in arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2016;214:228.
    PubMed     Text format    


  515. SMEETS CJ, Lanssens D, Gyselaers W, Bertrand PB, et al
    Detection of subclinical transient fluid accumulation during pregnancy in a patient with an implantable cardioverter defibrillator and OptiVol(R) fluid monitoring algorithm.
    Int J Cardiol. 2016;214:163-165.
    PubMed     Text format    


  516. KOTECHA D
    Letter: Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients - Response.
    Int J Cardiol. 2016 Mar 25. pii: S0167-5273(16)30529.
    PubMed     Text format    


  517. BOGOSSIAN H, Frommeyer G, Brachmann J, Lewalter T, et al
    Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry.
    Int J Cardiol. 2016;214:25-30.
    PubMed     Text format     Abstract available


  518. BASARAN O, Dogan V, Sahin C, Biteker M, et al
    Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation.
    Int J Cardiol. 2016;212:357.
    PubMed     Text format    


  519. MADIAS JE
    Bradycardia and hypotension in a patient with subarachnoid hemorrhage-triggered takotsubo syndrome.
    Int J Cardiol. 2016;212:296.
    PubMed     Text format    


  520. NIERRAS PC, Maranian AP, Wen MS, Chou CC, et al
    Radiofrequency Catheter Ablation of Orthodromic Atrioventricular Reentrant Tachycardia in a Child with Congenitally Corrected Transposition of the Great Arteries and Atrial Septal Defect.
    Int J Cardiol. 2016;212:277-279.
    PubMed     Text format    


  521. WANG W, Yuan R, Korantzopoulos P, Xu G, et al
    Cystatin C and risk of atrial fibrillation in elderly hypertensive patients without chronic kidney disease.
    Int J Cardiol. 2016;212:262-264.
    PubMed     Text format    


  522. OZEKE O, Aras S, Baser K, Sen F, et al
    Defensive medicine due to different fears by patients and physicians in geriatric atrial fibrillation patients and second victim syndrome.
    Int J Cardiol. 2016;212:251-252.
    PubMed     Text format    


  523. EFTEKHARI A, Damgaard D, Grove EL
    Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
    Int J Cardiol. 2016;214:131-132.
    PubMed     Text format    


  524. BAEK YS, Kim TH, Uhm JS, Kim JY, et al
    Prevalence and the clinical outcome of atrial fibrillation in patients with Autoimmune Rheumatic Disease.
    Int J Cardiol. 2016;214:4-9.
    PubMed     Text format     Abstract available


  525. ZHANG N, Chen KY, Zhao J, Xu G, et al
    Another side effect of ticagrelor: Atrial fibrillation.
    Int J Cardiol. 2016;212:242-244.
    PubMed     Text format    


  526. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
    Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
    Int J Cardiol. 2016;212:311-317.
    PubMed     Text format     Abstract available


  527. COLEMAN CI, Tangirala M, Evers T
    Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
    Int J Cardiol. 2016;212:171-173.
    PubMed     Text format    


  528. ANZINI M, Merlo M, Artico J, Sinagra G, et al
    Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias.
    Int J Cardiol. 2016;212:169-170.
    PubMed     Text format    


  529. GIAMUNDO A, Canciello G, Rapacciuolo A, Musella F, et al
    Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy.
    Int J Cardiol. 2016;212:198-200.
    PubMed     Text format    


  530. QIU J, Zhou S, Liu Q
    Energy metabolic alterations in the progression of atrial fibrillation: Potential role of AMP-activated protein kinase as a critical regulator.
    Int J Cardiol. 2016;212:14-15.
    PubMed     Text format    


  531. OZEKE O, Cay S, Ozcan F, Topaloglu S, et al
    Lateral ST elevation as a practical electrocardiographic clue for apical aneurysm in hypertrophic cardiomyopathy patients.
    Int J Cardiol. 2016;207:194-5.
    PubMed     Text format    


  532. PARATO VM, Scarano M, Cicchitti V, Cannava G, et al
    An interventricular and right intraventricular dyssynchrony related to right bundle branch block appearance as cause of RVOT gradient decrease in a HCM patient.
    Int J Cardiol. 2016;207:150-1.
    PubMed     Text format    


  533. LIM E, Wong T
    Is non-sustained ventricular tachycardia a predictor of sudden death in adults with congenital heart disease?
    Int J Cardiol. 2016;207:264-5.
    PubMed     Text format    


  534. PETERS S
    The correlation between epsilon wave and coved-type ST-segment elevation in a patient with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2016;207:230.
    PubMed     Text format    


  535. PETERS S
    Ion channel diseases as a part in the definition and classification of cardiomyopathies recently confirmed in Brugada syndrome.
    Int J Cardiol. 2016;207:103.
    PubMed     Text format    


  536. PETERS S
    Diagnosis of arrhythmogenic cardiomyopathy by localized right precordial QRS prolongation and inferior early repolarization phenomenon but without T-wave inversion.
    Int J Cardiol. 2016;207:97-9.
    PubMed     Text format    


  537. DAUMY X, Amarouch MY, Lindenbaum P, Bonnaud S, et al
    Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I.
    Int J Cardiol. 2016;207:349-58.
    PubMed     Text format     Abstract available


  538. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


  539. ARAS D, Topaloglu S, Ozeke O, Cay S, et al
    Left coronary cusp cryoablation guided by electroanatomic mapping for outflow ventricular arrhythmias.
    Int J Cardiol. 2016 Mar 3. pii: S0167-5273(16)30397.
    PubMed     Text format    


  540. OZEKE O, Cay S, Ozcan F, Baser K, et al
    Similarities between the renal artery and pulmonary vein denervation trials: Do we have to use sham procedures for atrial fibrillation catheter ablation trials?
    Int J Cardiol. 2016;211:55-57.
    PubMed     Text format    


  541. CHANG Q, Liu R
    True left bundle branch block?
    Int J Cardiol. 2016;211:112-114.
    PubMed     Text format    


  542. TEUWEN CP, Ramdjan TT, Gotte M, Brundel BJ, et al
    Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign?
    Int J Cardiol. 2016;206:158-63.
    PubMed     Text format     Abstract available


  543. D'AMATI G, De Caterina R, Basso C
    Sudden cardiac death in an Italian competitive athlete: Pre-participation screening and cardiovascular emergency care are both essential.
    Int J Cardiol. 2016;206:84-6.
    PubMed     Text format    


  544. CHOU CA, Zhou L, Blanchard MS
    Invasive vagal nerve stimulation causes delayed autonomic dysregulation: A case report.
    Int J Cardiol. 2016;206:19-20.
    PubMed     Text format    


    February 2016
  545. AKDIS D, Saguner AM, Brunckhorst CB, Duru F, et al
    Successful epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2016;211:22-24.
    PubMed     Text format    


  546. QIN M, Liu X, Jiang WF, Wu SH, et al
    Vagal response during pulmonary vein isolation: Re-recognized its characteristics and implications in lone paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;211:7-13.
    PubMed     Text format     Abstract available


  547. YAMABE H, Kanazawa H, Itoh M, Kaneko S, et al
    Difference in the maintenance mechanism of atrial fibrillation perpetuated after pulmonary vein isolation between paroxysmal and persistent atrial fibrillation: Effects of subsequent stepwise ablation.
    Int J Cardiol. 2016;210:109-118.
    PubMed     Text format     Abstract available


  548. MENG L, Yang Y, Zhang Z, Li G, et al
    Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: A meta-analysis.
    Int J Cardiol. 2016;210:68-71.
    PubMed     Text format    


  549. GANGA HV, Jantz J, Puppala VK
    Risk of incident atrial fibrillation with hypomagnesemia.
    Int J Cardiol. 2016 Feb 15. pii: S0167-5273(16)30241.
    PubMed     Text format    


  550. VILLATORO MA, Marquez MF, Gomez-Flores J, Nava S, et al
    Andersen-Tawil syndrome. A diagnostic challenge.
    Int J Cardiol. 2016;205:163-4.
    PubMed     Text format    


  551. GAL P, Elvan A, Rossi P, Schauerte P, et al
    Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics.
    Int J Cardiol. 2016;205:83-5.
    PubMed     Text format    


  552. ZHOU GB, Hu JQ, Guo XG, Liu X, et al
    Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar.
    Int J Cardiol. 2016;205:72-80.
    PubMed     Text format     Abstract available


  553. FURUTA A, Lellouche N, Mouillet G, Dhanjal T, et al
    Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.
    Int J Cardiol. 2016;210:72-79.
    PubMed     Text format     Abstract available


  554. HU X, Jiang J, Ma Y, Tang A, et al
    Is there still a role for additional linear ablation in addition to pulmonary vein isolation in patients with paroxysmal atrial fibrillation? An Updated Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;209:266-274.
    PubMed     Text format     Abstract available


  555. SCHERLAG BJ, Sun J, He B, Po SS, et al
    Optimal Sites for Renal Artery Denervation: Relation to atrial fibrillation ablation.
    Int J Cardiol. 2016;209:330-331.
    PubMed     Text format    


  556. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  557. PETERS S
    Differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and granulomatous myocarditis by advanced ECG analysis.
    Int J Cardiol. 2016;209:255-257.
    PubMed     Text format    


  558. SEO WK, Kang SH, Jung JM, Choi JY, et al
    Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
    Int J Cardiol. 2016;209:184-189.
    PubMed     Text format     Abstract available


  559. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease.
    Int J Cardiol. 2016;209:181-183.
    PubMed     Text format    


  560. TOPALOGLU S, Ozeke O, Ozcan F, Aras D, et al
    Anatomical considerations in accessory pathway ablation.
    Int J Cardiol. 2016;204:122-3.
    PubMed     Text format    


  561. KETTERER U, D'Ancona G, Siegel I, Ortak J, et al
    Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders.
    Int J Cardiol. 2016;204:196-7.
    PubMed     Text format    


  562. BUSUTTIL M, Willoughby S
    A survey of energy drink consumption among young patients presenting to the emergency department with the symptom of palpitations.
    Int J Cardiol. 2016;204:55-6.
    PubMed     Text format    


    January 2016
  563. BRIFFA T, Hung J, Knuiman M, McQuillan B, et al
    Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010.
    Int J Cardiol. 2016;208:19-25.
    PubMed     Text format     Abstract available


  564. QIU J, Zhou S, Liu Q
    Phosphorylated AMP-activated protein kinase slows down the atrial fibrillation progression by activating Connexin43.
    Int J Cardiol. 2016;208:56-57.
    PubMed     Text format    


  565. RUF T, Mues C, Tomala J, Ibrahim K, et al
    TAVR - A new way to treat ventricular storm and ventricular fibrillation.
    Int J Cardiol. 2016;208:36-39.
    PubMed     Text format    


  566. BALTA S, Demirkol S, Aparci M, Yildirim AO, et al
    Red blood cell distribution width: Just one of many things to consider.
    Int J Cardiol. 2016;203:438-9.
    PubMed     Text format    


  567. RAMOUTAR A, Bowker T, Kurbaan A, Xiao HB, et al
    Response to "Pacemaker indication in first-degree AV block patients: Factors beyond the PR interval/HR slope".
    Int J Cardiol. 2016;203:1152.
    PubMed     Text format    


  568. AKRAWINTHAWONG K, Mehdirad AA
    Pacemaker indication in first-degree AV block patients: Factors beyond the PR interval/HR slope.
    Int J Cardiol. 2016;203:1151.
    PubMed     Text format    


  569. CHAUDHRY UA, Harling L, Ashrafian H, Athanasiou C, et al
    Surgical management of infected cardiac implantable electronic devices.
    Int J Cardiol. 2016;203:714-21.
    PubMed     Text format     Abstract available


  570. PETERS S
    Brugada phenocopy in percutaneous coronary intervention of the right coronary artery.
    Int J Cardiol. 2016;203:675.
    PubMed     Text format    


  571. GIGANTE A, Rosato E, Liberatori M, Sardo L, et al
    In systemic sclerosis prolonged QTc interval is associated with reduced exercise tolerance.
    Int J Cardiol. 2016;203:570-2.
    PubMed     Text format    


  572. KALENDER E, Sensoy B, Cay S
    Heart block after herpes zoster reactivation.
    Int J Cardiol. 2016;203:549-50.
    PubMed     Text format    


  573. BATTAGLIA A, Anselmino M, Ferraris F, Gaita F, et al
    Left persistent superior vena cava as a source of focal atrial arrhythmias: A late arrhythmia recurrence due to a latent proximal focus.
    Int J Cardiol. 2016;203:523-4.
    PubMed     Text format    


  574. WILSON DG, Yue A, Roberts PR, Morgan JM, et al
    Leadless pacing: The old with the new.
    Int J Cardiol. 2016;203:407-8.
    PubMed     Text format    


  575. LEE YJ, Park JK, Uhm JS, Kim JY, et al
    Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Int J Cardiol. 2016;203:372-8.
    PubMed     Text format     Abstract available


  576. ONER T, Akdeniz C, Adaletli H
    Multifocal atrial tachycardia caused by risperidone.
    Int J Cardiol. 2016;203:855-7.
    PubMed     Text format     Abstract available


  577. LU Z, He B, He W, Xie J, et al
    Electrocardiographic characteristics of idiopathic premature ventricular contractions originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2016;203:5-11.
    PubMed     Text format     Abstract available


  578. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    


  579. BREMBILLA-PERROT B, Sellal JM, Olivier A, Villemin T, et al
    Electrophysiological study generally is negative in patients <40 years suspected of supraventricular tachycardia but also complaining of chest pain and/or syncope.
    Int J Cardiol. 2016;203:1109-13.
    PubMed     Text format     Abstract available


  580. SWEETING J, Ingles J, Ball K, Semsarian C, et al
    Sudden deaths during the largest community running event in Australia: A 25-year review.
    Int J Cardiol. 2016;203:1029-31.
    PubMed     Text format    


  581. ITO S, Stout KK, Robinson MR
    Non-sustained ventricular tachycardia in a pregnant woman with repaired Tetralogy of Fallot: A challenging case.
    Int J Cardiol. 2016;203:1133-4.
    PubMed     Text format    


  582. ROMANO P, Messina F, Crosca S
    Oral anticoagulant therapy and thrombosis. A case of failure of therapy with vitamin K antagonists.
    Int J Cardiol. 2016;203:1158-9.
    PubMed     Text format    


  583. SHAH N, Rochlani Y, Pothineni NV, Paydak H, et al
    Burden of arrhythmias in patients with multiple myeloma.
    Int J Cardiol. 2016;203:305-6.
    PubMed     Text format    


  584. JOLOBE OM
    Long term supervision as a crucial ingredient of all anticoagulant therapy.
    Int J Cardiol. 2016;203:278.
    PubMed     Text format    


  585. MADIAS JE
    Takotsubo syndrome/QTc interval prolongation/myocardial edema/cardiac sympathetic denervation/cardiac arrhythmias: A quintet needing exploration.
    Int J Cardiol. 2016;203:259-61.
    PubMed     Text format    


  586. BITEKER M, Basaran O, Dogan V
    Prediction of atrial fibrillation risk in the community.
    Int J Cardiol. 2016 Jan 14. pii: S0167-5273(16)30126.
    PubMed     Text format    


  587. PROIETTI M, Raparelli V, Basili S, Olshansky B, et al
    Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial.
    Int J Cardiol. 2016;207:258-263.
    PubMed     Text format     Abstract available


  588. PETERS S
    Tachycardiomyopathy: A case of dilated cardiomyopathy due to permanent junctional reentrant tachycardia.
    Int J Cardiol. 2016;207:233-234.
    PubMed     Text format    


  589. ZHANG X, Zhang Z, Li M, Li G, et al
    Potential role of dipeptidyl peptidase-4 inhibitors in atrial fibrillation.
    Int J Cardiol. 2016;207:46-47.
    PubMed     Text format    


  590. KEFER J, Tzikas A, Freixa X, Shakir S, et al
    Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Int J Cardiol. 2016;207:335-340.
    PubMed     Text format     Abstract available


  591. SANTOS-LOZANO A, Sanchis-Gomar F, Barrero-Santalla S, Pareja-Galeano H, et al
    Exercise as an adjuvant therapy against chronic atrial fibrillation.
    Int J Cardiol. 2016;207:180-184.
    PubMed     Text format    


  592. PETERS S
    A case of atrioventricular nodal reentrant tachycardia associated with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2016;207:143-144.
    PubMed     Text format    


  593. APARCI M, Uz O, Atalay M, Uzun M, et al
    May hypomagnesaemia; caused by proton pump inhibitor; increase atrial fibrillation risk?
    Int J Cardiol. 2016;207:141.
    PubMed     Text format    


  594. KIRAT T, Kose N, Altun I, Akin F, et al
    What is the role of routine ECG screening in stable coronary heart disease and effects of oral anticoagulant, antiarrhythmics in these patients with atrial fibrillation?
    Int J Cardiol. 2016;207:140.
    PubMed     Text format    


  595. KAYA H, Beton O, Yilmaz MB
    Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure.
    Int J Cardiol. 2016;207:136.
    PubMed     Text format    


  596. DARWICHE W, Bejan-Angoulvant T, Dievart F, Babuty D, et al
    Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings.
    Int J Cardiol. 2016;206:89-92.
    PubMed     Text format    


  597. SAWHNEY V, Campbell NG, Brouilette SW, Coppen SR, et al
    Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
    Int J Cardiol. 2016;207:157-163.
    PubMed     Text format     Abstract available


  598. MERINOPOULOS I, Raphael CE, Yardley A, Goonewardene M, et al
    Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?
    Int J Cardiol. 2016;207:378-381.
    PubMed     Text format     Abstract available


  599. SHAO Q, Korantzopoulos P, Fu H, Ye L, et al
    Effects of probucol on left atrial remodeling in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;207:117-119.
    PubMed     Text format    


  600. ONDRAKOVA M, Knot J, Ulman J, Maly M, et al
    Efficacy of P2Y receptor antagonists in patients with atrial fibrillation according to the CHADSVASc score.
    Int J Cardiol. 2016;207:84-86.
    PubMed     Text format    


  601. SECCIA TM, Caroccia B, Muiesan ML, Rossi GP, et al
    Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.
    Int J Cardiol. 2016;206:71-76.
    PubMed     Text format     Abstract available


  602. BAVISHI C, Khan AR, Ather S
    Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Int J Cardiol. 2016;206:56-57.
    PubMed     Text format    


  603. GOLDBERG A, Rosenfeld I, Nordkin I, Halabi M, et al
    Ticagrelor therapy in patients with advanced conduction disease: Is it really safe?
    Int J Cardiol. 2016;202:948-9.
    PubMed     Text format    


  604. CHRISTOS GA
    P-wave indices in emphysema. What do we actually know?
    Int J Cardiol. 2016;202:80.
    PubMed     Text format    


  605. ZARROUK-MAHJOUB S, Finsterer J
    Noncompaction with valve abnormalities is rarely associated with neurologic or genetic disease.
    Int J Cardiol. 2016;202:627-8.
    PubMed     Text format    


  606. DATINO T, Arenal A, Ruiz-Hernandez PM, Pelliza M, et al
    Arrhythmia ablation using the Amigo Robotic Remote Catheter System versus manual ablation: One year follow-up results.
    Int J Cardiol. 2016;202:877-8.
    PubMed     Text format    


  607. HUANG SY, Chen YC, Kao YH, Hsieh MH, et al
    Renal failure induces atrial arrhythmogenesis from discrepant electrophysiological remodeling and calcium regulation in pulmonary veins, sinoatrial node, and atria.
    Int J Cardiol. 2016;202:846-57.
    PubMed     Text format     Abstract available


  608. HUNG MJ, Mao CT, Yang NI, Kao YC, et al
    Delayed recovery of anger-induced electrocardiographic T-wave alternans and T-wave inversion in a previously healthy woman.
    Int J Cardiol. 2016;202:707-9.
    PubMed     Text format    


  609. GIALAFOS E, Andreadou E, Kokotis P, Evangelopoulos ME, et al
    Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
    Int J Cardiol. 2016;202:652-3.
    PubMed     Text format    


  610. VAN DER BOON RM, van Huysduynen BH, Meuwissen M, Schaap J, et al
    Ventricular tachycardia: The challenge of two diagnoses.
    Int J Cardiol. 2016;202:226-7.
    PubMed     Text format    


  611. SOLIMENE F, Donnici G, Shopova G, Nappi F, et al
    Trends in fluoroscopy time during radiofrequency catheter ablation of supraventricular tachycardias.
    Int J Cardiol. 2016;202:124-5.
    PubMed     Text format    


  612. PARATO VM, Scarano M, Cicchitti V, Cannava G, et al
    Involvement of the right ventricle in hypertrophic cardiomyopathy and occurrence of right bundle branch block.
    Int J Cardiol. 2016;202:75-6.
    PubMed     Text format    


  613. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
    Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Int J Cardiol. 2016;202:578-85.
    PubMed     Text format     Abstract available


  614. NISHIMURA K, Funabashi N, Takahashi Y, Hasegawa H, et al
    Cardiac Fabry disease with plural mass fibrosis observed in the thickened left ventricular wall.
    Int J Cardiol. 2016;202:552-5.
    PubMed     Text format    


  615. XIA W, Liu Y
    Targeted ablation of cardiac sympathetic neurons: A promising approach to prevent sudden cardiac death.
    Int J Cardiol. 2016;202:425-6.
    PubMed     Text format    


  616. SOMMESE L, Valverde CA, Blanco P, Castro MC, et al
    Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
    Int J Cardiol. 2016;202:394-406.
    PubMed     Text format     Abstract available


    December 2015
  617. MARKOVITS N, Kurnik D, Halkin H, Margalit R, et al
    Database evaluation of the association between serum magnesium levels and the risk of atrial fibrillation in the community.
    Int J Cardiol. 2015;205:142-146.
    PubMed     Text format     Abstract available


  618. DIOUF I, Magliano DJ, Carrington MJ, Stewart S, et al
    Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study.
    Int J Cardiol. 2015;205:127-132.
    PubMed     Text format     Abstract available


  619. LEE A, See VA, Lim TW, Descallar J, et al
    Atrial fibrillation ablation by single ring isolation versus wide antral isolation: Effects on left atrial size and function.
    Int J Cardiol. 2015;206:1-6.
    PubMed     Text format     Abstract available


  620. CHHABRA L, Gurukripa Kowlgi N
    Cardiac adipose tissue: Distinction between epicardial and pericardial fat remains important!
    Int J Cardiol. 2015;201:274-5.
    PubMed     Text format    


    November 2015
  621. KOIFMAN E, Lipinski MJ, Escarcega RO, Didier R, et al
    Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis.
    Int J Cardiol. 2015;205:17-22.
    PubMed     Text format     Abstract available


  622. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
    Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
    Int J Cardiol. 2015;203:906-908.
    PubMed     Text format    


  623. PETERS S
    Refugee from Syria presents with chest pain due to arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;204:59-60.
    PubMed     Text format    


  624. SZYMANSKI FM, Lip GY, Filipiak KJ, Platek AE, et al
    Usefulness of the SAME-TTR score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
    Int J Cardiol. 2015;204:200-205.
    PubMed     Text format     Abstract available


  625. CEKIRDEKCI E, Emre E
    e-Comment: There is no magic bullet to predict postoperative atrial fibrillation.
    Int J Cardiol. 2015;204:114.
    PubMed     Text format    


  626. ZHAO J, Liu T, Korantzopoulos P, Letsas KP, et al
    Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis.
    Int J Cardiol. 2015;204:103-105.
    PubMed     Text format    


  627. VELOSO HH, Chaves JC, Jazbik Sobrinho J
    Inappropriate shocks of implantable cardioverter-defibrillator during central venous access: A preventable complication.
    Int J Cardiol. 2015;204:61-63.
    PubMed     Text format    


  628. VELOSO HH
    Underutilization of implantable cardioverter-defibrillator in studies proposing risk scores to predict death in Chagas heart disease: Just a reflection of the real world.
    Int J Cardiol. 2015;203:1082-1083.
    PubMed     Text format    


  629. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
    Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
    Int J Cardiol. 2015;203:1014-1015.
    PubMed     Text format    


  630. HE B, Lu Z, He W, Huang B, et al
    Ventricular arrhythmias as an autoimmune disorder?
    Int J Cardiol. 2015;203:1011-1012.
    PubMed     Text format    


  631. KUNDU A, Sen P, Sardar P, Chatterjee S, et al
    Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2015;203:1000-1002.
    PubMed     Text format    


  632. ANCEDY Y, Lecoq C, Saint Etienne C, Ivanes F, et al
    Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
    Int J Cardiol. 2015;203:987-994.
    PubMed     Text format     Abstract available


  633. TOKATLI A, Yiginer O
    Altered atrial conduction in postoperative atrial fibrillation.
    Int J Cardiol. 2015;203:945-946.
    PubMed     Text format    


  634. LIP GY, Mitchell SA, Liu X, Liu LZ, et al
    Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Int J Cardiol. 2015;204:88-94.
    PubMed     Text format     Abstract available


  635. PETERS S
    Unusual cause of chest pain in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;204:13-14.
    PubMed     Text format    


  636. KATO S, Foppa M, Roujol S, Basha T, et al
    Left ventricular native T time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2015;203:848-854.
    PubMed     Text format     Abstract available


  637. NEDIOS S, Seewoster T, Lip GH, Husser D, et al
    Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
    Int J Cardiol. 2015;203:621-623.
    PubMed     Text format    


  638. LI H, Liu T, Xu G, Liu E, et al
    Red blood cell distribution width and the recurrence of atrial fibrillation after ablation in patients with paroxysmal non-valvular symptomatic atrial fibrillation.
    Int J Cardiol. 2015;203:834-836.
    PubMed     Text format    


  639. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
    A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
    Int J Cardiol. 2015;203:785-790.
    PubMed     Text format     Abstract available


  640. MATSUBARA TJ, Fujiu K, Asada K, Kojima T, et al
    Direct left atrial ICE imaging guided ablation for atrial fibrillation without employing contrast medium.
    Int J Cardiol. 2015;203:733-739.
    PubMed     Text format     Abstract available


  641. YANG Y, Liu Q, Wu Z, Li X, et al
    Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;203:624-625.
    PubMed     Text format    


  642. OZTURK C, Unlu M, Yildirim AO, Erdogan S, et al
    The progressed atrioventricular block associated with ticagrelor therapy may not require permanent pacemaker after acute coronary syndrome; it may be reversible.
    Int J Cardiol. 2015;203:822-824.
    PubMed     Text format    


  643. QIU J, Hu H, Zhou S, Liu Q, et al
    Alteration of myocardium glucose metabolism in atrial fibrillation: Cause or effect?
    Int J Cardiol. 2015;203:722-723.
    PubMed     Text format    


    October 2015
  644. KATO Y, Suzuki S, Kano H, Semba H, et al
    Prognostic significance of exercise capacity and resting heart rate: Comparison between atrial fibrillation and sinus rhythm.
    Int J Cardiol. 2015;203:561-563.
    PubMed     Text format    


  645. EYUBOGLU M
    Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
    Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
    PubMed     Text format    


  646. KOTECHA D, Chudasama R, Lane DA, Kirchhof P, et al
    Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Int J Cardiol. 2015;203:660-666.
    PubMed     Text format     Abstract available


  647. LIU Y, Zhang Z, Yang Y, Zhang N, et al
    The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation.
    Int J Cardiol. 2015;203:614-615.
    PubMed     Text format    


  648. LIU T, Meng XY, Li T, Fu ZL, et al
    Atherosclerosis is critical in the pathogenesis of erectile dysfunction.
    Int J Cardiol. 2015;203:367-368.
    PubMed     Text format    


  649. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
    Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
    PubMed     Text format    


  650. AMASYALI B, Tek M
    The type of spontaneous termination of supraventricular tachycardia: What does it tell us?
    Int J Cardiol. 2015;196:29-30.
    PubMed     Text format    


    September 2015
  651. HE B, Huang B, Lu Z, He W, et al
    Galectin-3: A potential new target for upstream therapy of atrial fibrillation.
    Int J Cardiol. 2015 Sep 29. pii: S0167-5273(15)30500.
    PubMed     Text format    


  652. HUANG Y, Huang W, Hu Y
    Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Int J Cardiol. 2015 Sep 27. pii: S0167-5273(15)30521.
    PubMed     Text format    


  653. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
    REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
    Int J Cardiol. 2015;203:882-884.
    PubMed     Text format    


  654. LINDE C, Curtis AB, Fonarow GC, Lee K, et al
    Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Int J Cardiol. 2015;202:349-355.
    PubMed     Text format     Abstract available


  655. FERNANDEZ-CISNAL A, Arce-Leon A, Arana-Rueda E, Rodriguez-Manero M, et al
    Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses.
    Int J Cardiol. 2015;195:188-94.
    PubMed     Text format     Abstract available


  656. PIJUAN-DOMENECH A, Galian L, Goya M, Casellas M, et al
    Cardiac complications during pregnancy are better predicted with the modified WHO risk score.
    Int J Cardiol. 2015;195:149-54.
    PubMed     Text format     Abstract available


  657. OLDE NORDKAMP LR, Brouwer TF, Barr C, Theuns DA, et al
    Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Int J Cardiol. 2015;195:126-33.
    PubMed     Text format     Abstract available


  658. EL MAZLOUM R, Snenghi R, Zorzi A, Zilio F, et al
    Out-of-hospital cardiac arrest after acute cocaine intoxication associated with Brugada ECG patterns: Insights into physiopathologic mechanisms and implications for therapy.
    Int J Cardiol. 2015;195:245-9.
    PubMed     Text format    


  659. MADIAS JE
    Delving into the issue of life-threatening arrhythmias in patients with Takotsubo syndrome.
    Int J Cardiol. 2015;195:215.
    PubMed     Text format    


  660. LIU F, Li Y, Xu Y
    Weight loss to prevent atrial fibrillation: The role of epicardial adipose tissue.
    Int J Cardiol. 2015;204:124-125.
    PubMed     Text format    


    August 2015
  661. CAY S, Ozcan F, Ozeke O, Aras D, et al
    Accessory pathway ablation in a patient with situs inversus totalis and Wolff-Parkinson-White electrocardiographic pattern: Mirror approach.
    Int J Cardiol. 2015;193:34-5.
    PubMed     Text format    


  662. RENILLA A, Rubin JM, Rozado J, Moris C, et al
    Long-term evolution of pacemaker dependency after percutaneous aortic valve implantation with the corevalve prosthesis.
    Int J Cardiol. 2015;201:61-63.
    PubMed     Text format    


    July 2015
  663. CHIALE PA, Baranchuk A, Gonzalez MD, Sanchez RA, et al
    The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
    Int J Cardiol. 2015;191:151-8.
    PubMed     Text format     Abstract available


  664. VAN MALDEREN SC, Kerkhove D, Theuns DA, Weytjens C, et al
    Prolonged right ventricular ejection delay identifies high risk patients and gender differences in Brugada syndrome.
    Int J Cardiol. 2015;191:90-6.
    PubMed     Text format     Abstract available


  665. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
    P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
    Int J Cardiol. 2015;190:202-4.
    PubMed     Text format    


    June 2015
  666. CARMO AA, Rocha MO, Silva JL, Ianni BM, et al
    Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease.
    Int J Cardiol. 2015;189:182-4.
    PubMed     Text format    


  667. TSAI WC, Lu YY, Chen YC, Chang CJ, et al
    Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
    Int J Cardiol. 2015;189:172-81.
    PubMed     Text format     Abstract available


    May 2015
  668. AKSU U, Topcu S, Gulcu O, Kalkan K, et al
    Diastolic mitral and tricuspid regurgitation in a patient with 2:1 AV block.
    Int J Cardiol. 2015;195:111-112.
    PubMed     Text format    


  669. RAMUSCHKAT M, Appelbaum S, Atzler D, Zeller T, et al
    ADMA, subclinical changes and atrial fibrillation in the general population.
    Int J Cardiol. 2015;203:640-646.
    PubMed     Text format     Abstract available


    April 2015
  670. PETERS S
    Provocable coved-type ST-segment elevation in right precordial leads as initial ECG feature after successful resuscitation with developing arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;185:136-7.
    PubMed     Text format    


  671. ESPERER HD, Bajer M, Hahn J, Braun-Dullaeus RC, et al
    Effects of dronedarone on ventricular repolarization and repolarization dynamics in patients with preserved left ventricular systolic function.
    Int J Cardiol. 2015;185:119-21.
    PubMed     Text format    


  672. XI Y, Honeywell C, Zhang D, Schwartzentruber J, et al
    Whole exome sequencing identifies the TNNI3K gene as a cause of familial conduction system disease and congenital junctional ectopic tachycardia.
    Int J Cardiol. 2015;185:114-6.
    PubMed     Text format    


  673. CARBUCICCHIO C, Al Mohani G, Casella M, Pizzamiglio F, et al
    Uncommon ventricular tachycardia originating from an interventricular septal aneurism: Mapping and ablation guided by real-time image integration.
    Int J Cardiol. 2015;185:103-5.
    PubMed     Text format    


  674. OHLOW MA, von Korn H, Lauer B
    Characteristics and outcome of congenital left ventricular aneurysm and diverticulum: Analysis of 809 cases published since 1816.
    Int J Cardiol. 2015;185:34-45.
    PubMed     Text format     Abstract available


  675. CANPOLAT U
    Isolation of the Pandorra's box and end of the evils in left atrium.
    Int J Cardiol. 2015;185:7-8.
    PubMed     Text format    


  676. CHANG CJ, Cheng CC, Yang TF, Chen YC, et al
    Selective and non-selective non-steroidal anti-inflammatory drugs differentially regulate pulmonary vein and atrial arrhythmogenesis.
    Int J Cardiol. 2015;184:559-67.
    PubMed     Text format     Abstract available


  677. ZHANG E, Liu T, Li Z, Zhao J, et al
    High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
    Int J Cardiol. 2015;184:540-2.
    PubMed     Text format    


  678. DE MARIA GL, Pedersen M, Leo M, Bashir Y, et al
    Iatrogenic constrictive remodeling of left main stem after left coronary cusp atrial tachycardia ablation.
    Int J Cardiol. 2015;184:507-9.
    PubMed     Text format    


  679. TARUYA A, Tanaka A, Nishiguchi T, Iwaguro T, et al
    Necessity of magnetic resonance imaging examinations after permanent pacemaker implantation.
    Int J Cardiol. 2015;184:497-8.
    PubMed     Text format    


  680. GHAFOOR A, Janardhanan R
    Takotsubo cardiomyopathy: Utility of cardiac magnetic resonance to stratify risk for sudden cardiac death.
    Int J Cardiol. 2015;184:492-3.
    PubMed     Text format    


  681. EINDHOVEN JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, et al
    High-sensitive troponin-T in adult congenital heart disease.
    Int J Cardiol. 2015;184:405-11.
    PubMed     Text format     Abstract available


  682. MONTAIGNE D, Marechal X, Lacroix D, Staels B, et al
    From cardiac mitochondrial dysfunction to clinical arrhythmias.
    Int J Cardiol. 2015;184:597-9.
    PubMed     Text format    


  683. BRUNETTI ND, De Gennaro L, Santoro F, Guaricci AI, et al
    VT or not VT: That is the question.
    Int J Cardiol. 2015;184:391-3.
    PubMed     Text format    


  684. YETKIN E
    An extremely rare presentation of supraventricular tachycardia: Burping.
    Int J Cardiol. 2015;184:369-70.
    PubMed     Text format    


  685. KLIS M, Slawuta A, Gajek J
    Antiarrhythmic properties of atrial pacing - Alternative sites or better pharmacotherapy or both?
    Int J Cardiol. 2015;184:294-5.
    PubMed     Text format    


  686. HISAMATSU T, Miura K, Fujiyoshi A, Okamura T, et al
    Long-term outcomes associated with prolonged PR interval in the general Japanese population.
    Int J Cardiol. 2015;184:291-3.
    PubMed     Text format    


  687. ZUBERI Z, Jogiya R, Behr ER
    VERP in Brugada syndrome - Very effective risk predictor?
    Int J Cardiol. 2015;184:270-1.
    PubMed     Text format    


  688. SANTOS-PARDO I, Villuendas R, Salvador-Corres I, Martinez-Morillo M, et al
    Anti-Ro/SSA antibodies and cardiac rhythm disturbances: Present and future perspectives.
    Int J Cardiol. 2015;184:244-50.
    PubMed     Text format     Abstract available


    March 2015
  689. NWAKILE C, Purushottam B, Bhalla V, Ukpong D, et al
    Significance of QRS duration in non-ST elevation myocardial infarction.
    Int J Cardiol. 2015;187:146-147.
    PubMed     Text format    


  690. WALTER C, Rottler E, von Wietersheim J, Cuntz U, et al
    QT-correction formulae and arrhythmogenic risk in female patients with anorexia nervosa.
    Int J Cardiol. 2015;187:302-303.
    PubMed     Text format    


  691. FRAGAKIS N, Antoniadis AP, Saviano M, Vassilikos V, et al
    The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives.
    Int J Cardiol. 2015;183:267-73.
    PubMed     Text format     Abstract available


  692. CALKOEN EE, Vicente-Steijn R, Hahurij ND, van Munsteren CJ, et al
    Abnormal sinoatrial node development resulting from disturbed vascular endothelial growth factor signaling.
    Int J Cardiol. 2015;183:249-57.
    PubMed     Text format     Abstract available


  693. UDO EO, van Hemel NM, Zuithoff NP, Doevendans PA, et al
    Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing.
    Int J Cardiol. 2015;185:95-100.
    PubMed     Text format     Abstract available


  694. LAU YM, Hui WM, Lau CP
    Asystole complicating acalculous cholecystitis, the "Cope's sign" revisited.
    Int J Cardiol. 2015;182:447-8.
    PubMed     Text format    


  695. PINTO C, Samuel BP, Ratnasamy C, Vettukattil JJ, et al
    Thrombosis in Fontan patient on apixaban.
    Int J Cardiol. 2015;182:66-7.
    PubMed     Text format    


  696. PETERS S
    Is early sudden death in the course of arrhythmogenic cardiomyopathy due to initial Brugada syndrome?
    Int J Cardiol. 2015;182:107-8.
    PubMed     Text format    


  697. THONGPRAYOON C, Cheungpasitporn W, Srivali N, Kittanamongkolchai W, et al
    Incidence of acute kidney injury in reported cases of lead related cardiac perforation.
    Int J Cardiol. 2015;182:65.
    PubMed     Text format    


  698. SULTAN A, Luker J, Hoffmann B, Servatius H, et al
    Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach.
    Int J Cardiol. 2015;182:56-61.
    PubMed     Text format     Abstract available


  699. YETKIN E, Kaleagzi FC
    Recovery of absence seizure-like symptoms in a patient after slow pathway radiofrequency ablation.
    Int J Cardiol. 2015;182:44-5.
    PubMed     Text format    


  700. ROSATO E, Gigante A, Liberatori M, Gasperini ML, et al
    QTc interval prolongation in systemic sclerosis: correlations with clinical variables.
    Int J Cardiol. 2015;182:20-2.
    PubMed     Text format    


  701. SANTORO F, Pellegrino PL, D'Arienzo G, Ziccardi L, et al
    "A cold shower": electrical magnetic interference caused by water heater current leakage through shower water pipe inducing ICD shock.
    Int J Cardiol. 2015;182:279-80.
    PubMed     Text format    


    February 2015
  702. ROSMAN L, Whited A, Lampert R, Mosesso VN, et al
    Cardiac anxiety after sudden cardiac arrest: Severity, predictors and clinical implications.
    Int J Cardiol. 2015;181:73-6.
    PubMed     Text format     Abstract available


  703. FRERE C, Laine M, Paganelli F, Dignat-George F, et al
    Antiplatelet properties of oral anticoagulants.
    Int J Cardiol. 2015;181:413-4.
    PubMed     Text format    


  704. BELL JR, Raaijmakers AJ, Curl CL, Reichelt ME, et al
    Cardiac CaMKIIdelta splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.
    Int J Cardiol. 2015;181:288-96.
    PubMed     Text format     Abstract available


  705. SENOO K, Lane DA, Lip GY
    Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Int J Cardiol. 2015;181:247-54.
    PubMed     Text format     Abstract available


  706. KORNEJ J, Hindricks G, Arya A, Sommer P, et al
    Presence and extent of coronary artery disease as predictor for AF recurrences after catheter ablation: The Leipzig Heart Center AF Ablation Registry.
    Int J Cardiol. 2015;181:188-92.
    PubMed     Text format     Abstract available


  707. FORD I, Robertson M, Komajda M, Bohm M, et al
    Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.
    Int J Cardiol. 2015;184C:163-169.
    PubMed     Text format     Abstract available


    January 2015
  708. JIN Q, Jacobsen PK, Pehrson S, Chen X, et al
    Acute and long term outcomes of catheter ablation using remote magnetic navigation for the treatment of electrical storm in patients with severe ischemic heart failure.
    Int J Cardiol. 2015;183C:11-16.
    PubMed     Text format     Abstract available


  709. HEIDENDAEL JF, Bokma JP, de Groot JR, Koolbergen DR, et al
    Weighing the risks: Thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease.
    Int J Cardiol. 2015;186:315-20.
    PubMed     Text format     Abstract available


  710. LIAO Z, Zhan X, Wu S
    Successful radiofrequency ablation of a parahisian accessory pathway from the right coronary cusp.
    Int J Cardiol. 2015;186:41-2.
    PubMed     Text format    


  711. DATTILO G, Scarano M, Casale M, Sergi M, et al
    An atypical manifestation of Twiddler syndrome.
    Int J Cardiol. 2015;186:1-2.
    PubMed     Text format    


  712. PETERS S
    Vectorcardiography: diagnostic advantage over electrocardiography in arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;187:134-7.
    PubMed     Text format    


  713. GUPTA T, Khera S, Kolte D, Aronow WS, et al
    Antiarrhythmic properties of ranolazine: A review of the current evidence.
    Int J Cardiol. 2015;187:66-74.
    PubMed     Text format     Abstract available


  714. LAMBERTI F, Di Clemente F, Remoli R, Bellini C, et al
    Catheter ablation of idiopathic ventricular tachycardia without the use of fluoroscopy.
    Int J Cardiol. 2015;190:338-43.
    PubMed     Text format     Abstract available


  715. DILAVERIS P, Tsioufis C, Gatzoulis K, Tousoulis D, et al
    Extreme prolongation of sinus node recovery time in a coronary artery disease patient.
    Int J Cardiol. 2015;190:260-1.
    PubMed     Text format    


  716. LITTMANN L, Saxonhouse SJ
    Repetitive, incessant supraventricular tachycardia: Noninvasive determination of the electrophysiologic mechanism.
    Int J Cardiol. 2015;190:256-9.
    PubMed     Text format    


  717. LUO XX, Fang F, Yu CM
    Advantageous effect of biventricular pacing on cardiac function and coronary flow: A case report.
    Int J Cardiol. 2015;190:236-8.
    PubMed     Text format    


  718. ROMANO G, Raffa GM, Ruggieri A, Sgarito G, et al
    Recurrent ventricular tachycardia in a patient with continuous flow left ventricle assist device: Successful management with radiofrequency ablation and medical treatment.
    Int J Cardiol. 2015;190:198-200.
    PubMed     Text format    


  719. ENRIQUEZ A, Ali FS, Boles U, Michael K, et al
    Unipolar voltage threshold of 5.0 mV is optimal to localize critical isthmuses in post-infarction patients presenting with ventricular tachycardia.
    Int J Cardiol. 2015;187:438-42.
    PubMed     Text format     Abstract available


  720. TERNACLE J, Boiron P, Gallet R, Champagne S, et al
    Contribution of ultrasound contrast in predicting conduction disturbances during percutaneous alcohol septal ablation.
    Int J Cardiol. 2015;187:436-7.
    PubMed     Text format    


  721. SHIUE I
    Heart murmur and dysrhythmia are associated with accidents leading to poor mental health and cognition: Scottish Health Survey, 2013.
    Int J Cardiol. 2015;187:322-4.
    PubMed     Text format    


  722. LIU Z, Yu J, Fang PH, He J, et al
    Double device left atrial appendage closure with the WATCHMAN.
    Int J Cardiol. 2015;187:281-2.
    PubMed     Text format    


  723. IMRAN TF, Niazi OT, Amin R, Mazza V, et al
    Risperidone unmasking an accessory pathway.
    Int J Cardiol. 2015;187:488-90.
    PubMed     Text format    


    December 2014
  724. WONG GR, Lau DH, Baillie TJ, Middeldorp ME, et al
    Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'
    Int J Cardiol. 2014;181C:55-56.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: